The clonal evolution of tumor cell populations.
paper
Cited
Public
Unavailable
- Authors
- Nowell, P C
- Year
- 1976
- Journal
- Science (New York, N.Y.)
- PMID
- 959840
- DOI
- 10.1126/science.959840
It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | 2012 | 22561516 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| 5mC and 5hmC methylation sequencing: the power of 6-base sequencing in a multiomic era. | Crawford R et al. | β | 2026 | β |
| Advances in Colorectal Cancer Cell Biology and Clonal Evolution. | Toghey S et al. | β | 2026 | β |
| A Physical Framework to Control Cancer Cell Heterogeneity and Plasticity. | De Blander H et al. | β | 2026 | β |
| Bridging the gap between tumor evolution and clonality diagnostics in multiple lung carcinomas. | Janssen J et al. | β | 2026 | β |
| Cancer in 4D: toward Spatiotemporal Hallmark Ecosystems. | Sibai M et al. | β | 2026 | β |
| Development and Validation of Prognostic Models in Patients With Stage IV Thyroid Cancer Undergoing Surgical Treatment. | Ouyang L et al. | β | 2026 | β |
| Drugs and natural bioactive products in modulation of inflammatory pathways in cancer: preclinical and clinical evidence of inflammasomes, cytokine networks, and macrophage polarization. | Parsa S et al. | β | 2026 | β |
| Dynamic ecosystems of tumor drug resistance mechanisms: from molecular heterogeneity to systemic interventions. | Bao Q et al. | β | 2026 | β |
| Emerging trends and converging evidence in tumor evolution: A comprehensive review. | Jin C et al. | β | 2026 | β |
| Exploration of a framework to identify cohort of concern substances in medical device risk assessment. | Weng MW et al. | β | 2026 | β |
| General-purpose topology-aware embedding of tumor phylogenetic trees with graph neural networks. | Bresolin P et al. | β | 2026 | β |
| Haplotype-aware segmentation with HapASeg increases accuracy of detecting homolog-specific somatic copy number alterations. | Priebe O et al. | β | 2026 | β |
| Identification of cancer mini-drivers by deciphering selective landscape in the cancer genome. | Zhu X et al. | β | 2026 | β |
| Inferring and summarizing tumor phylogenies from bulk DNA data. | Qi Y et al. | β | 2026 | β |
| In Silico Analysis of Human NEK10 Reveals Novel Domain Architecture and Protein-Protein Interactions. | Eichner AS et al. | β | 2026 | β |
| Intratumoral heterogeneity in microsatellite instability status at single-cell resolution. | Anthony H et al. | β | 2026 | β |
| Inverse game theory characterizes frequency-dependent selection driven by karyotypic diversity in triple-negative breast cancer. | Veith T et al. | β | 2026 | β |
| Is cancer the result of uncontrolled cellular growth? a glance into the tumorigenic process. | Castro-Oropeza R et al. | β | 2026 | β |
| Lineage plasticity: a new dilemma in lung cancer treatment. | Huo C et al. | β | 2026 | β |
| Mapping intratumor heterogeneity across layers for advancing immunotherapy. | Marine JC et al. | β | 2026 | β |
| Multidimensional tumor heterogeneity and its role in therapeutic resistance. | Mubin N et al. | β | 2026 | β |
| NQO1-Responsive Prodrug for in Cellulo Release of Cytochalasin B as Cancer Cell-Targeted Migrastatic. | Kagho MD et al. | β | 2026 | β |
| Optimal control theory as a method for designing multidrug adaptive therapy regimens. | Widdershins A et al. | β | 2026 | β |
| Pharming: Joint Clonal Tree Reconstruction of Single-Nucleotide Variant and Copy Number Aberration Evolution from Single-Cell DNA Sequencing of Tumors. | Weber LL et al. | β | 2026 | β |
| Polyclonal origins of human premalignant colorectal lesions. | Van Egeren D et al. | β | 2026 | β |
| Pristine B<sub>40</sub> fullerene as a potential gemcitabine drug carrier for anti-lung cancer properties: a DFT and QTAIM study. | Sukumar AN et al. | β | 2026 | β |
| Prophylactic and therapeutic CSC-based vaccination reduced tumor growth, metastasis and enhanced survival in mouse model of breast cancer. | Dehghan Manshadi M et al. | β | 2026 | β |
| StarCDP: Dynamic Programming Algorithms for Fast and Accurate Cell Lineage Tree Reconstruction from CRISPR-Based Lineage Tracing Data. | Dai J et al. | β | 2026 | β |
| Targeting extrachromosomal DNA in human cancers. | Wong IT et al. | β | 2026 | β |
| The Role of Selection for Function in Aging and Chronic Diseases: A Novel Evolutionary Perspective. | Dujon AM et al. | β | 2026 | β |
| Tumour promotion through the lens of evolution. | Lopez-Bigas N et al. | β | 2026 | β |
| Adaptive cancer therapy: can non-genetic factors become its achilles heel? | Valcz G et al. | β | 2025 | β |
| Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence. | Derbal Y | β | 2025 | β |
| Advances in CRISPR-Cas9 in lineage tracing of model animals. | Cao J et al. | β | 2025 | β |
| A graph homomorphism approach for unraveling histories of metastatic cancers and viral outbreaks under evolutionary constraints. | Kuzmin K et al. | β | 2025 | β |
| Analysis of clonal evolution in cancer: A computational perspective. | Ribeiro PH et al. | β | 2025 | β |
| Anesthesiology and Perioperative Care of the Cancer Patient: Enhancing Lives and Improving Outcomes. | Gottumukkala V et al. | β | 2025 | β |
| An integrative phenotype-structured partial differential equation model for the population dynamics of epithelial-mesenchymal transition. | Guilberteau J et al. | β | 2025 | β |
| A possible role for epigenetics in cancer initiation. | Martinez AM et al. | β | 2025 | β |
| Applications and emerging challenges of single-cell RNA sequencing technology in tumor drug discovery. | Zhang L et al. | β | 2025 | β |
| Asymmetric cell division of ALDH1-positive cancer stem cells generates glycolytic metabolically diverse cell populations. | Tamori S et al. | β | 2025 | β |
| A systematic literature review on clonal evolution events preceding relapse in multiple myeloma. | Jakobsen MZ et al. | β | 2025 | β |
| Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation. | Zhang Y et al. | β | 2025 | β |
| Bayesian inference of fitness landscapes via tree-structured branching processes. | Luo XG et al. | β | 2025 | β |
| Biological Activity and Therapeutic Potential of Coumarin Derivatives: A Comprehensive Review. | Singh S et al. | β | 2025 | β |
| Breast Cancer: Molecular Pathogenesis and Targeted Therapy. | Samad MA et al. | β | 2025 | β |
| Cancer Biology and the Perioperative Period: Opportunities for Disease Evolution and Challenges for Perioperative Care. | Perry NJS et al. | β | 2025 | β |
| Cancer cells' chamber of secrets: the link between micronuclei, chromothripsis and malignancy. | Mcneil TR et al. | β | 2025 | β |
| Cancer stem cells: Bridging microenvironmental interactions and clinical therapy. | Wang H et al. | β | 2025 | β |
| Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer. | Nwokolo GC et al. | β | 2025 | β |
| Cancer stem cells: Masters of all traits. | Leck LYW et al. | β | 2025 | β |
| Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer. | Ma S et al. | β | 2025 | β |
| Clinical Validation of a Machine Learning-Based Biomarker Signature to Predict Response to Cytotoxic Chemotherapy Alone or Combined with Targeted Therapy in Metastatic Colorectal Cancer Patients: A Study Protocol and Review. | Pagano D et al. | β | 2025 | β |
| Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers. | Erickson A et al. | β | 2025 | β |
| Clone copy number diversity is linked to survival in lung cancer. | Pawlik P et al. | β | 2025 | β |
| CluVar: clustering of variants using autoencoder for inferring cancer subclones from single cell RNA sequencing data. | Kim CW et al. | β | 2025 | β |
| CNRein: an evolution-aware deep reinforcement learning algorithm for single-cell DNA copy number calling. | Ivanovic S et al. | β | 2025 | β |
| Comparison of Side Effects of Anti-epidermal Growth Factor Receptor (Anti-EGFR) Antibody Drugs During Initial Induction and Reinduction in Colorectal Cancer: A Case Series. | Hoshida T et al. | β | 2025 | β |
| Computational strategies in tumor phylogenetics: evaluating multimodal integration and methodological trade-offs across study designs. | Jiang C et al. | β | 2025 | β |
| Cooperative nutrient scavenging is an evolutionary advantage in cancer. | Guzelsoy G et al. | β | 2025 | β |
| Death-ision: the link between cellular resilience and cancer resistance to treatments. | Baldassarre G et al. | β | 2025 | β |
| Deciphering the liver's role in pancreatic cancer metastasis: pathways and therapeutic approaches. | Inzunza J et al. | β | 2025 | β |
| Deconvolution and phylogeny inference of diverse variant types integrating bulk DNA-seq with single-cell RNA-seq. | Bristy NA et al. | β | 2025 | β |
| DelSIEVE: cell phylogeny modeling of single nucleotide variants and deletions from single-cell DNA sequencing data. | Kang S et al. | β | 2025 | β |
| DICE: fast and accurate distance-based reconstruction of single-cell copy number phylogenies. | Weiner S et al. | β | 2025 | β |
| Dosimetry in Advanced Thyroid Cancer: A Piece of a Puzzle? | Nappi C et al. | β | 2025 | β |
| EIF4A3-Induced hsa_circ_0118578 Expression Enhances the Tumorigenesis of Papillary Thyroid Cancer. | Li C et al. | β | 2025 | β |
| Epigenetic Regulation in Drosophila Tumor Models. | Martinez AM | β | 2025 | β |
| Evolutionary paths towards metastasis. | Naxerova K | β | 2025 | β |
| Exosome transmit the ability of migration and invasion in heterogeneous ovarian cancer cells by regulating autophagy via targeting hsa-miR-328. | Sun H et al. | β | 2025 | β |
| Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies. | Bonato V et al. | β | 2025 | β |
| Filtering for Highly Variable Genes and High-Quality Spots Improves Phylogenetic Analysis of Cancer Spatial Transcriptomics Visium Data. | Gavryushkina AS et al. | β | 2025 | β |
| Fluctuating DNA methylation tracks cancer evolution at clinical scale. | Gabbutt C et al. | β | 2025 | β |
| Functional phenotyping of genomic variants using joint multiomic single-cell DNA-RNA sequencing. | Lindenhofer D et al. | β | 2025 | β |
| Generative AI - Assisted Adaptive Cancer Therapy. | Derbal Y | β | 2025 | β |
| Genetic background and oncogenic driver determines the genomic evolution and transcriptomics of mammary tumor metastasis. | Ross CR et al. | β | 2025 | β |
| Genome-level selection in tumors as a universal marker of resistance to therapy. | Persi E et al. | β | 2025 | β |
| High resolution clonal architecture of hypomutated Wilms tumours. | Lee-Six H et al. | β | 2025 | β |
| Identification of Phenotypically Distinct Cancer Stem Cell Subpopulations in Oral Squamous Cell Carcinoma. | Osman TA et al. | β | 2025 | β |
| Immunogenomic cancer evolution: A framework to understand cancer immunosuppression. | Kumagai S et al. | β | 2025 | β |
| IMOP-Cancer: identifying mutation order pairs impacting cancer phenotypes. | Zhang Y et al. | β | 2025 | β |
| Implications of intratumoral microbiota in tumor metastasis: a special perspective of microorganisms in tumorigenesis and clinical therapeutics. | Zhang L et al. | β | 2025 | β |
| Induction of cancer stem cells from mouse fibroblasts. | Shabrish S et al. | β | 2025 | β |
| Integrin and Its Associated Proteins as a Mediator for Mechano-Signal Transduction. | Katoh K | β | 2025 | β |
| Intratumoral heterogeneity and drug resistance in cancer. | Fu YC et al. | β | 2025 | β |
| Intra-tumoral spatial heterogeneity in breast cancer quantified using high-dimensional protein multiplexing and single cell phenotyping. | Cheung AM et al. | β | 2025 | β |
| In vivo targeted and deterministic single-cell malignant transformation. | Scerbo P et al. | β | 2025 | β |
| Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations. | Matsumoto Y et al. | β | 2025 | β |
| Leveraging selection for function in tumor evolution: System-level cancer therapies. | Thomas F et al. | β | 2025 | β |
| Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC. | Mazzaschi G et al. | β | 2025 | β |
| Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma. | Dummer R et al. | β | 2025 | β |
| <i>Curcumae Rhizoma</i>: An anti-cancer traditional Chinese medicine. | Luo Y et al. | β | 2025 | β |
| Macrophages promote tumor growth by phagocytosis-mediated cytokine amplification in Drosophila. | Hirooka E et al. | β | 2025 | β |
| Many are called but few are chosen-from multiple clonal origins to one winner. | Chen Q et al. | β | 2025 | β |
| Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma. | Kader T et al. | β | 2025 | β |
| MyClone: rapid and precise reconstruction of clonal population structures for tumors. | Guo Q et al. | β | 2025 | β |
| Netrin-1-UNC5B/neogenin axis enhances the stemness of colorectal cancer cells. | Xia X et al. | β | 2025 | β |
| Physics-informed AI with chemical master equation dynamics for driver-gene subclone detection and risk labeling. | Atitey K et al. | β | 2025 | β |
| Prognostic impact of ER-staining patterns and heterogeneity of ER positive HER2 negative breast cancer. | Akita Y et al. | β | 2025 | β |
| Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation. | Fedele C et al. | β | 2025 | β |
| Proximate and ultimate causes of pregnancy sickness. | Stadtmauer DJ | β | 2025 | β |
| PSMG2 role in tumorigenesis and stemness mediated by protein accumulation, reticulum stress and autophagy. | Espinosa-SΓ‘nchez A et al. | β | 2025 | β |
| Radiobiological Modeling with Monte Carlo Tools - Simulating Cellular Responses to Ionizing Radiation. | Azevedo TA et al. | β | 2025 | β |
| Recurrent hepatocellular carcinoma is associated with the enrichment of MYC targets gene sets, elevated high confidence deleterious mutations and alternative splicing of DDB2 and BRCA1 transcripts. | KaraosmanoΔlu O | β | 2025 | β |
| Re-evaluating Stem Cell Roles in Homeostasis and Cancer of the Esophagus. | Kostic L et al. | β | 2025 | β |
| Refining biomarker design in light of cancer evolution. | β | β | 2025 | β |
| Regulating Lipid Metabolism <i>via</i> Mitochondrial Dynamics in Tongue Squamous Cell Carcinoma Cancer Stem Cells. | Wu F et al. | β | 2025 | β |
| Research progress of colorectal cancer in genomic and transcriptomic at multi-level. | Wen Q et al. | β | 2025 | β |
| Revisiting Clonal Evolution Through the Light of Retrotransposons. | Lamoureux A et al. | β | 2025 | β |
| RNA polymerase II at histone genes predicts outcome in human cancer. | Henikoff S et al. | β | 2025 | β |
| Role of intratumoral heterogeneity in metastatic progression and drug resistance. | Sinai Borker N et al. | β | 2025 | β |
| Sc-TUSV-Ext: Single-Cell Clonal Lineage Inference from Single Nucleotide Variants, Copy Number Alterations, and Structural Variants. | Bristy NA et al. | β | 2025 | β |
| Sociobiology meets oncology: unraveling altruistic cooperation in cancer cells and its implications. | Bin Masroni MS et al. | β | 2025 | β |
| State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment. | Giron-Michel J et al. | β | 2025 | β |
| Stochastic modeling of single-cell gene expression adaptation reveals non-genomic contribution to evolution of tumor subclones. | Hirsch MG et al. | β | 2025 | β |
| Taming cancer evolution surprises. | Marx V | β | 2025 | β |
| Targeting metastasis in paediatric bone sarcomas. | Bull EC et al. | β | 2025 | β |
| Tfcp2l1 as a central integrator of hypoxia, dedifferentiation, and tumor progression. | Clemente-GonzΓ‘lez C et al. | β | 2025 | β |
| The Emerging Role of Peroxisome Proliferator-Activated Receptors in Cancer Stemness. | Parejo-Alonso B et al. | β | 2025 | β |
| The end of the genetic paradigm of cancer. | Huang S et al. | β | 2025 | β |
| The Hallmarks of Cancer as Eco-Evolutionary Processes. | Bhattacharya R et al. | β | 2025 | β |
| Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications. | Mao S et al. | β | 2025 | β |
| Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia. | Kamizela AE et al. | β | 2025 | β |
| Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing. | Andersson N et al. | β | 2025 | β |
| Trans-Scale Insights into Variability in Radiation Cancer Risk Across Tissues, Individuals, and Species. | Imaoka T | β | 2025 | β |
| Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML). | LaganΓ A et al. | β | 2025 | β |
| A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data. | Qiao Y et al. | β | 2024 | β |
| Adaptive Cancer Therapy in the Age of Generative Artificial Intelligence. | Derbal Y | β | 2024 | β |
| A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma. | Wu PV et al. | β | 2024 | β |
| Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice. | Kulesza A et al. | β | 2024 | β |
| Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis. | Bernstein N et al. | β | 2024 | β |
| Analyzing somatic mutations by single-cell whole-genome sequencing. | Zhang L et al. | β | 2024 | β |
| Anchorage Dependence and Cancer Metastasis. | Lee DK et al. | β | 2024 | β |
| A new perspective on tumor progression: Evolution via selection for function. | Thomas F et al. | β | 2024 | β |
| A Novel Affordable and Reliable Framework for Accurate Detection and Comprehensive Analysis of Somatic Mutations in Cancer. | Atzeni R et al. | β | 2024 | β |
| A novel bioinformatic approach reveals cooperation between Cancer/Testis genes in basal-like breast tumors. | LaisnΓ© M et al. | β | 2024 | β |
| Applications of single-cell technologies in drug discovery for tumor treatment. | Liu B et al. | β | 2024 | β |
| Are 19del and L858R really different disease entities? | Kim S et al. | β | 2024 | β |
| Assessing the merits: an opinion on the effectiveness of simulation techniques in tumor subclonal reconstruction. | Lai J et al. | β | 2024 | β |
| Association of <i>BRAF</i> V600E Mutant Allele Proportion with the Dissemination Stage of Papillary Thyroid Cancer. | Blazekovic I et al. | β | 2024 | β |
| A Subset of Microsatellite Unstable Cancer Genomes Prone to Short Insertions over Deletions Is Associated with Elevated Anticancer Immunity. | Kim S et al. | β | 2024 | β |
| Belling the "cat": Wnt/Ξ²-catenin signaling and its significance in future cancer therapies. | Goyal A et al. | β | 2024 | β |
| CaClust: linking genotype to transcriptional heterogeneity of follicular lymphoma using BCR and exomic variants. | Oksza-Orzechowski K et al. | β | 2024 | β |
| Cancer as a Disease of Development Gone Awry. | Stanger BZ et al. | β | 2024 | β |
| Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance. | Maleki EH et al. | β | 2024 | β |
| Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. | Bhat GR et al. | β | 2024 | β |
| Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked? | Fatma H et al. | β | 2024 | β |
| Cancerous time estimation for interpreting the evolution of lung adenocarcinoma. | Han Y et al. | β | 2024 | β |
| Cancer stem cell mimicry for immune evasion and therapeutic resistance. | Saw PE et al. | β | 2024 | β |
| Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges. | Acharya SK et al. | β | 2024 | β |
| Cell-cell fusion in cancer: The next cancer hallmark? | Shultes PV et al. | β | 2024 | β |
| Cell competition and cancer from Drosophila to mammals. | Cong B et al. | β | 2024 | β |
| Cell competition in primary and metastatic colorectal cancer. | van Luyk ME et al. | β | 2024 | β |
| Cell type evolution reconstruction across species through cell phylogenies of single-cell RNA sequencing data. | Mah JL et al. | β | 2024 | β |
| Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer. | Park SS et al. | β | 2024 | β |
| Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review). | Diniz CHP et al. | β | 2024 | β |
| Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma. | Kacar Z et al. | β | 2024 | β |
| Characterizing chromosomal instability-driven cancer evolution and cell fitness at a glance. | Tijhuis AE et al. | β | 2024 | β |
| Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. | Xu J et al. | β | 2024 | β |
| Circulating tumor DNA: from discovery to clinical application in breast cancer. | Xu J et al. | β | 2024 | β |
| Clinical and Therapeutic Implications of Clonal Hematopoiesis. | Petrone G et al. | β | 2024 | β |
| Clinical application of tumour-in-normal contamination assessment from whole genome sequencing. | Mitchell J et al. | β | 2024 | β |
| Clinical Tumor Dormancy. | Demicheli R et al. | β | 2024 | β |
| Clonal differences underlie variable responses to sequential and prolonged treatment. | Schaff DL et al. | β | 2024 | β |
| Clonal expansion in normal tissues. | Maeda H et al. | β | 2024 | β |
| Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. | Gajagowni S et al. | β | 2024 | β |
| Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer. | Wang L et al. | β | 2024 | β |
| Consensus Tree Under the Ancestor-Descendant Distance is NP-Hard. | Qi Y et al. | β | 2024 | β |
| CopyMix: Mixture model based single-cell clustering and copy number profiling using variational inference. | Safinianaini N et al. | β | 2024 | β |
| Correcting for Observation Bias in Cancer Progression Modeling. | Schill R et al. | β | 2024 | β |
| Decoding the interplay between genetic and non-genetic drivers of metastasis. | Karras P et al. | β | 2024 | β |
| Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial Sections. | Schupp PG et al. | β | 2024 | β |
| Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells. | Blaszczak W et al. | β | 2024 | β |
| Epigenetic reprogramming shapes the cellular landscape of schwannoma. | Liu SJ et al. | β | 2024 | β |
| Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to ask. | Ruz-Caracuel I et al. | β | 2024 | β |
| Evolvability of cancer-associated genes under APOBEC3A/B selection. | Song JH et al. | β | 2024 | β |
| Evolving copy number gains promote tumor expansion and bolster mutational diversification. | Wang Z et al. | β | 2024 | β |
| Examination of the role of mutualism in immune evasion. | Gourmet L et al. | β | 2024 | β |
| Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies. | Li Q et al. | β | 2024 | β |
| Exploration of identifying individual tumor tissue based on probabilistic model. | Hu Y et al. | β | 2024 | β |
| Extrinsic and intrinsic drivers of natural killer cell clonality. | RΓΌckert T et al. | β | 2024 | β |
| Frequency-dependent selection of neoantigens fosters tumor immune escape and predicts immunotherapy response. | Chen S et al. | β | 2024 | β |
| Genetic and non-genetic drug resistance: Darwin or Lamarck? | Russo M | β | 2024 | β |
| Genomic evolution shapes prostate cancer disease type. | Woodcock DJ et al. | β | 2024 | β |
| Heterogeneity and molecular landscape of melanoma: implications for targeted therapy. | Beigi YZ et al. | β | 2024 | β |
| Histological transformation in lung adenocarcinoma: Insights of mechanisms and therapeutic windows. | Tan N et al. | β | 2024 | β |
| [Hypothesis of Genetic Diversity Selection in the Occurrence and Development of β©Lung Cancer: Molecular Evolution and Clinical Significance]. | Liu B | β | 2024 | β |
| Immune evasion impacts the landscape of driver genes during cancer evolution. | Gourmet L et al. | β | 2024 | β |
| Inferring replication timing and proliferation dynamics from single-cell DNA sequencing data. | Weiner AC et al. | β | 2024 | β |
| Inhibitor of Wnt receptor 1 suppresses the effects of Wnt1, Wnt3a and Ξ²βcatenin on the proliferation and migration of C6 GSCs induced by lowβdose radiation. | Yan Y et al. | β | 2024 | β |
| Insight into the evolution of breast cancer driven by genetic alterations. | Fang C et al. | β | 2024 | β |
| In silico study of heterogeneous tumour-derived organoid response to CAR T-cell therapy. | Luque LM et al. | β | 2024 | β |
| Integrating frontiers: a holistic, quantum and evolutionary approach to conquering cancer through systems biology and multidisciplinary synergy. | Casotti MC et al. | β | 2024 | β |
| Intercellular Molecular Transfer Mediated by Extracellular Vesicles in Cancer. | Adnani L et al. | β | 2024 | β |
| Intertumoral and intratumoral barriers as approaches for drug delivery and theranostics to solid tumors using stimuli-responsive materials. | Chenab KK et al. | β | 2024 | β |
| Islands of genomic stability in the face of genetically unstable metastatic cancer. | Bowland K et al. | β | 2024 | β |
| iSubGen generates integrative disease subtypes by pairwise similarity assessment. | Fox NS et al. | β | 2024 | β |
| Ketone bodies in cell physiology and cancer. | Giuliani G et al. | β | 2024 | β |
| Life history dynamics of evolving tumors: insights into task specialization, trade-offs, and tumor heterogeneity. | Ahmed M et al. | β | 2024 | β |
| Lineage and ecology define liver tumor evolution in response to treatment. | Revsine M et al. | β | 2024 | β |
| LinG3D: visualizing the spatio-temporal dynamics of clonal evolution. | Hu A et al. | β | 2024 | β |
| Malignant tumor cells engender second membrane-lined organelles for self-protection and tumor progression. | Yi T et al. | β | 2024 | β |
| Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation. | Ashrafizadeh M et al. | β | 2024 | β |
| Multifaceted perspectives of detecting and targeting solid tumors. | Bhattacharya A et al. | β | 2024 | β |
| Multifactorial drug carrier system bringing both chemical and physical therapeutics to the treatment of tumor heterogeneity. | Nam EJ et al. | β | 2024 | β |
| Multi-scale transcriptomics reveals that specific tumor cells promote lung adenocarcinoma metastasis through crosstalk with the microenvironment. | Cai Q et al. | β | 2024 | β |
| Mutations, substitutions, and selection: Linking mutagenic processes to cancer using evolutionary theory. | Cannataro VL et al. | β | 2024 | β |
| New generalized metric based on branch length distance to compare B cell lineage trees. | Farnia M et al. | β | 2024 | β |
| Oncogenic composite mutations can be predicted by co-mutations and their chromosomal location. | Küçükosmanoglu A et al. | β | 2024 | β |
| Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies. | Mishra R | β | 2024 | β |
| Orchard: Building large cancer phylogenies using stochastic combinatorial search. | Kulman E et al. | β | 2024 | β |
| Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist. | Svec J et al. | β | 2024 | β |
| Periodontitis and risk of cancer: Mechanistic evidence. | Baima G et al. | β | 2024 | β |
| Phenotypic, Genomic, and Transcriptomic Heterogeneity in a Pancreatic Cancer Cell Line. | Xie G et al. | β | 2024 | β |
| Plasticity and resistance of cancer stem cells as a challenge for innovative anticancer therapies - do we know enough to overcome this? | Knopik-Skrocka A et al. | β | 2024 | β |
| Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives. | Hashimoto A et al. | β | 2024 | β |
| Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis. | Sadien ID et al. | β | 2024 | β |
| Precision cancer classification using liquid biopsy and advanced machine learning techniques. | Eledkawy A et al. | β | 2024 | β |
| Predictability: A new distinguishing feature of cancer? | Gofrit ON et al. | β | 2024 | β |
| Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. | Kumagai S et al. | β | 2024 | β |
| Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review. | Tuo Z et al. | β | 2024 | β |
| Reprogramming the tumor microenvironment - macrophages emerge as key players in breast cancer immunotherapy. | Sami A et al. | β | 2024 | β |
| Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer. | Majocha MR et al. | β | 2024 | β |
| Resolving tumor evolution: a phylogenetic approach. | Li L et al. | β | 2024 | β |
| Rethinking the pathogenesis of endometriosis: Complex interactions of genomic, epigenetic, and environmental factors. | Kobayashi H et al. | β | 2024 | β |
| scGAL: unmask tumor clonal substructure by jointly analyzing independent single-cell copy number and scRNA-seq data. | Li R et al. | β | 2024 | β |
| Shifting the Cancer Screening Paradigm: Developing a Multi-Biomarker Class Approach to Multi-Cancer Early Detection Testing. | Kisiel JB et al. | β | 2024 | β |
| Short-sighted evolution of virulence for invasive gut microbes: From hypothesis to tests. | Scanlan PD et al. | β | 2024 | β |
| Simulation of Somatic Evolution Through the Introduction of Random Mutation to the Rules of Conway's Game of Life. | King MR | β | 2024 | β |
| Somatic mutations in aging and disease. | Ren P et al. | β | 2024 | β |
| Spatial transcriptomics identifies RBM39 as a gene a<b>ssociated with</b> Gleason score progression in prostate cancer. | Quan Y et al. | β | 2024 | β |
| Systems Biology Modeling of Cancer Nonlinear Dynamics. | Alameddine A | β | 2024 | β |
| The Epigenetic Hallmarks of Cancer. | Esteller M et al. | β | 2024 | β |
| The evolutionary theory of cancer: challenges and potential solutions. | Laplane L et al. | β | 2024 | β |
| The Importance of Monitoring Non-clonal Chromosome Aberrations (NCCAs) in Cancer Research. | Heng E et al. | β | 2024 | β |
| The molecular map of CLL and Richter's syndrome. | Sud A et al. | β | 2024 | β |
| The origin of novel traits in cancer. | Frank SA et al. | β | 2024 | β |
| The reckoning of chromosomal instability: past, present, future. | Lynch A et al. | β | 2024 | β |
| The role of chaperone-mediated autophagy in drug resistance. | Teixeira ABDS et al. | β | 2024 | β |
| The Spiral Model of Evolution: Stable Life Forms of Organisms and Unstable Life Forms of Cancers. | Kasperski A et al. | β | 2024 | β |
| The Wnt signaling pathway in hepatocellular carcinoma: Regulatory mechanisms and therapeutic prospects. | Ma S et al. | β | 2024 | β |
| Tumor-Agnostic Therapy-The Final Step Forward in the Cure for Human Neoplasms? | El-Sayed MM et al. | β | 2024 | β |
| Tumor Metabolism: A New Field for the Treatment of Glioma. | Chai X et al. | β | 2024 | β |
| Tumor phylogeography reveals block-shaped spatial heterogeneity and the mode of evolution in Hepatocellular Carcinoma. | Liu X et al. | β | 2024 | β |
| What can we learn about acid-base transporters in cancer from studying somatic mutations in their genes? | White B et al. | β | 2024 | β |
| When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian Clock. | Bieuville M et al. | β | 2024 | β |
| 3D Bioprinting for Tumor Metastasis Research. | Lin M et al. | β | 2023 | β |
| Accumulation of STR-Loci Aberrations in Subclones of Jurkat Cell Line as a Model of Tumor Clonal Evolution. | Risinskaya N et al. | β | 2023 | β |
| Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment. | Peroni E et al. | β | 2023 | β |
| Adopted neoplastic cells and the consequences of their existence. | Lazebnik Y | β | 2023 | β |
| A Law of Redundancy Compounds the Problem of Cancer and Precision Medicine. | Singh RS | β | 2023 | β |
| Amazing roles of extrachromosomal DNA in cancer progression. | Zhao L et al. | β | 2023 | β |
| Analysis of Somatic Mutations in Senescent Cells Using Single-Cell Whole-Genome Sequencing. | Zhang L et al. | β | 2023 | β |
| An epigenetic signature of advanced colorectal cancer metastasis. | Rodger EJ et al. | β | 2023 | β |
| A Poisson distribution-based general model of cancer rates and a cancer risk-dependent theory of aging. | Yu W et al. | β | 2023 | β |
| A weighted distance-based approach for deriving consensus tumor evolutionary trees. | Guang Z et al. | β | 2023 | β |
| A zero-agnostic model for copy number evolution in cancer. | Schmidt H et al. | β | 2023 | β |
| B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination. | Schichman SA et al. | β | 2023 | β |
| Bmi-1: A master regulator of head and neck cancer stemness. | Herzog AE et al. | β | 2023 | β |
| bmVAE: a variational autoencoder method for clustering single-cell mutation data. | Yan J et al. | β | 2023 | β |
| Cancer as an infective disease: the role of EVs in tumorigenesis. | Robado de Lope L et al. | β | 2023 | β |
| Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine. | Nurminen A et al. | β | 2023 | β |
| Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance. | Nairuz T et al. | β | 2023 | β |
| Cell Adaptive Fitness and Cancer Evolutionary Dynamics. | Derbal Y | β | 2023 | β |
| Cell competition in development, homeostasis and cancer. | van Neerven SM et al. | β | 2023 | β |
| Cellular barcoding tracks heterogeneous clones through selective pressures and phenotypic transitions. | Howland KK et al. | β | 2023 | β |
| Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer. | Castellanos G et al. | β | 2023 | β |
| Chromosomal Instability in Genome Evolution: From Cancer to Macroevolution. | Comaills V et al. | β | 2023 | β |
| Chromosome instability and aneuploidy in the mammalian brain. | Albert O et al. | β | 2023 | β |
| Clinical Progression of a Paraganglioma Over Many Years in a Man With Congenital Heart Disease. | McConnell MM et al. | β | 2023 | β |
| Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia. | Woodward EL et al. | β | 2023 | β |
| Clonal selection parallels between normal and cancer tissues. | Salavaty A et al. | β | 2023 | β |
| Considerations for modelling diffuse high-grade gliomas and developing clinically relevant therapies. | Higginbottom SL et al. | β | 2023 | β |
| Convergent TP53 loss and evolvability in cancer. | Mansur MB et al. | β | 2023 | β |
| Decoding Cancer Evolution: Integrating Genetic and Non-Genetic Insights. | Ashouri A et al. | β | 2023 | β |
| Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies. | Andrade JR et al. | β | 2023 | β |
| Early clonal extinction in glioblastoma progression revealed by genetic barcoding. | Ceresa D et al. | β | 2023 | β |
| Emerging roles of intratumor microbiota in cancer metastasis. | Fu A et al. | β | 2023 | β |
| Epigenetics as a mediator of plasticity in cancer. | Feinberg AP et al. | β | 2023 | β |
| Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. | Liu Y et al. | β | 2023 | β |
| Evolutionary determinants of curability in cancer. | Mansur MB et al. | β | 2023 | β |
| Evolutionary genomic analysis for ALL. | Harmon LM et al. | β | 2023 | β |
| Evolution-Informed Strategies for Combating Drug Resistance in Cancer. | Lin-Rahardja K et al. | β | 2023 | β |
| Evolution tumour models paving the way for understanding oral carcinogenesis. | Martins-Chaves RR et al. | β | 2023 | β |
| Evolution within the body: the rise and fall of somatic Darwinism in the late nineteenth century. | Swiatczak B | β | 2023 | β |
| Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome. | El Khoury LY et al. | β | 2023 | β |
| FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma. | Zhang W et al. | β | 2023 | β |
| From Pathogens to Cancer: Are Cancer Cells Evolved Mitochondrial Super Cells? | Balzanelli MG et al. | β | 2023 | β |
| FTO regulates the DNA damage response via effects on cell-cycle progression. | Liu W et al. | β | 2023 | β |
| Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA. | Campani C et al. | β | 2023 | β |
| How cancer hijacks the body's homeostasis through the neuroendocrine system. | Slominski RM et al. | β | 2023 | β |
| How protons pave the way to aggressive cancers. | Swietach P et al. | β | 2023 | β |
| <i>Carcino-Evo-Devo</i>, A Theory of the Evolutionary Role of Hereditary Tumors. | Kozlov AP | β | 2023 | β |
| Immunotargeting of Cancer Stem Cells. | KΓΆseer AS et al. | β | 2023 | β |
| Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer. | Thakur S et al. | β | 2023 | β |
| Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer. | Rao Y et al. | β | 2023 | β |
| Inferring the Cancer Cellular Epigenome Heterogeneity via DNA Methylation Patterns. | Li S | β | 2023 | β |
| Insight into the Basic Mechanisms and Various Modulation Strategies Involved in Cancer Drug Resistance. | Yadav D et al. | β | 2023 | β |
| Interfacial Organization and Forces Arising from Epithelial-Cancerous Monolayer Interactions. | Guan LY et al. | β | 2023 | β |
| Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma. | Kock Am Brink M et al. | β | 2023 | β |
| Intratumor heterogeneity in colorectal cancer: Distribution of tumor suppressor gene variants with regard to patient lymph node status. | WΔ tor G et al. | β | 2023 | β |
| Joint inference of exclusivity patterns and recurrent trajectories from tumor mutation trees. | Luo XG et al. | β | 2023 | β |
| Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3βcm Without Vascular Invasion: A Propensity Score-Matched Survival Analysis. | Wong LL et al. | β | 2023 | β |
| Low RPMB indicates better disease-free survival of adjuvant radiotherapy after radical surgery in thymoma. | An N et al. | β | 2023 | β |
| Machine learning based combination of multi-omics data for subgroup identification in non-small cell lung cancer. | Khadirnaikar S et al. | β | 2023 | β |
| Mathematical modeling of neuroblastoma associates evolutionary patterns with outcomes. | Caravagna G | β | 2023 | β |
| METTL3 regulates breast cancer-associated alternative splicing switches. | Achour C et al. | β | 2023 | β |
| Microphysiological systems to study colorectal cancer: state-of-the-art. | Ramos P et al. | β | 2023 | β |
| Microscopy-based phenotypic monitoring of MDA-MB-231 spheroids allows the evaluation of phenotype-directed therapy. | Mahmoud L et al. | β | 2023 | β |
| Modeling and predicting cancer clonal evolution with reinforcement learning. | Ivanovic S et al. | β | 2023 | β |
| Modeling cancer's ecological and evolutionary dynamics. | Bukkuri A et al. | β | 2023 | β |
| Modeling the Role of Immune Cell Conversion in the Tumor-Immune Microenvironment. | Moffett AS et al. | β | 2023 | β |
| Multiscale quantification of morphological heterogeneity with creation of a predictor of longer survival in glioblastoma. | Prokop G et al. | β | 2023 | β |
| Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal "unity of ecology and evolution" pathological ecosystem. | Luo W | β | 2023 | β |
| New advances in circulating tumor cellβmediated metastasis of breast cancer (Review). | Zhou JS et al. | β | 2023 | β |
| New insights into the correlations between circulating tumor cells and target organ metastasis. | Zhan Q et al. | β | 2023 | β |
| Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. | Brisset M et al. | β | 2023 | β |
| Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy. | Taborska P et al. | β | 2023 | β |
| Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies. | Rafik ST et al. | β | 2023 | β |
| Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells. | Chamorro GonzΓ‘lez R et al. | β | 2023 | β |
| Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks. | Romualdo GR et al. | β | 2023 | β |
| Phertilizer: Growing a clonal tree from ultra-low coverage single-cell DNA sequencing of tumors. | Weber LL et al. | β | 2023 | β |
| Phylogenetic inference from single-cell RNA-seq data. | Liu X et al. | β | 2023 | β |
| Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. | Su GH et al. | β | 2023 | β |
| Rapid assessment of 3-dimensional intra-tumor heterogeneity through cycling temperature capillary electrophoresis. | PoΕeΔ A et al. | β | 2023 | β |
| Rational combinations of targeted cancer therapies: background, advances and challenges. | Jin H et al. | β | 2023 | β |
| Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics. | Jun SH et al. | β | 2023 | β |
| Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity. | Watkins TBK et al. | β | 2023 | β |
| Reuniting philosophy and science to advance cancer research. | Pradeu T et al. | β | 2023 | β |
| Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production. | Perrault EN et al. | β | 2023 | β |
| RobustTree: An adaptive, robust PCA algorithm for embedded tree structure recovery from single-cell sequencing data. | Chen Z et al. | β | 2023 | β |
| Role of vascular smooth muscle cell clonality in atherosclerosis. | Luo L et al. | β | 2023 | β |
| Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer. | Singh B et al. | β | 2023 | β |
| Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants. | Landau J et al. | β | 2023 | β |
| Single-Cell and Transcriptome-Based Immune Cell-Related Prognostic Model in Clear Cell Renal Cell Carcinoma. | Wu G et al. | β | 2023 | β |
| Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues. | BorgsmΓΌller N et al. | β | 2023 | β |
| Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer. | Hou Z et al. | β | 2023 | β |
| Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression. | Wu B et al. | β | 2023 | β |
| Spatial biology of cancer evolution. | Seferbekova Z et al. | β | 2023 | β |
| Spontaneously occurring tumors in different wild-derived strains of hydra. | Boutry J et al. | β | 2023 | β |
| Synergistic inter-clonal cooperation involving crosstalk, co-option and co-dependency can enhance the invasiveness of genetically distant cancer clones. | Carneiro CS et al. | β | 2023 | β |
| The Evolutionary Landscape of Colorectal Tumorigenesis: Recent Paradigms, Models, and Hypotheses. | van Ginkel J et al. | β | 2023 | β |
| The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities. | Boylan J et al. | β | 2023 | β |
| The most likely but largely ignored triggering factor for breast (or all) cancer invasion. | Man YG et al. | β | 2023 | β |
| The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis. | Occhiuto CJ et al. | β | 2023 | β |
| The need for evolutionary theory in cancer research. | Boddy AM | β | 2023 | β |
| Therapeutic Effects of Coumarins with Different Substitution Patterns. | Flores-Morales V et al. | β | 2023 | β |
| Therapeutic Targeting of DNA Replication Stress in Cancer. | Gu L et al. | β | 2023 | β |
| The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma. | Cierpikowski P et al. | β | 2023 | β |
| The role of physics in multiomics and cancer evolution. | Gourmet LE et al. | β | 2023 | β |
| The Significance of Cancer Stem Cells and Epithelial-Mesenchymal Transition in Metastasis and Anti-Cancer Therapy. | Liang L et al. | β | 2023 | β |
| Timed hazard networks: Incorporating temporal difference for oncogenetic analysis. | Chen J | β | 2023 | β |
| Toward a systems-level probing of tumor clonality. | Grody EI et al. | β | 2023 | β |
| Towards a Synthesis of the Non-Genetic and Genetic Views of Cancer in Understanding Pancreatic Ductal Adenocarcinoma Initiation and Prevention. | Gopalan V et al. | β | 2023 | β |
| Tracing cancer evolution and heterogeneity using Hi-C. | Erdmann-Pham DD et al. | β | 2023 | β |
| Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. | Hu J et al. | β | 2023 | β |
| Tumor Microenvironment Role in Pancreatic Cancer Stem Cells. | Galindo-Vega A et al. | β | 2023 | β |
| Unraveling the Drivers of Tumorigenesis in the Context of Evolution: Theoretical Models and Bioinformatics Tools. | Zhu X et al. | β | 2023 | β |
| Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications. | Saoudi GonzΓ‘lez N et al. | β | 2023 | β |
| Utilization of Functionalized Metal-Organic Framework Nanoparticle as Targeted Drug Delivery System for Cancer Therapy. | Tran VA et al. | β | 2023 | β |
| Viruses, cancers, and evolutionary biology in the clinic: aΒ commentary on Leeks et al. 2023. | Γ gren JA et al. | β | 2023 | β |
| Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer. | Quan Y et al. | β | 2023 | β |
| Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA. | Zhou C et al. | β | 2023 | β |
| [About some theories of oncogenesis]. | Robert J | β | 2022 | β |
| Accurate Identification of Subclones in Tumor Genomes. | Ahmadinejad N et al. | β | 2022 | β |
| Accurate tumor clonal structures require single-cell analysis. | Su X et al. | β | 2022 | β |
| A "conversion-deterioration-double mutation" theory for the evolution and progression of colorectal cancer. | Wang R et al. | β | 2022 | β |
| A Detailed Overview About the Single-Cell Analyses of Solid Tumors Focusing on Colorectal Cancer. | Kothalawala WJ et al. | β | 2022 | β |
| A mathematical model to study the impact of intra-tumour heterogeneity on anti-tumour CD8<sup>+</sup> T cell immune response. | Leschiera E et al. | β | 2022 | β |
| A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannoma. | Paterson C et al. | β | 2022 | β |
| An Epigenetic Role of Mitochondria in Cancer. | Liu Y et al. | β | 2022 | β |
| Anesthetics and Long Term Cancer Outcomes: May Epigenetics Be the Key for Pancreatic Cancer? | Mokini Z et al. | β | 2022 | β |
| Application and prospect of single-cell sequencing in cancer metastasis. | Zheng Y et al. | β | 2022 | β |
| Artificial intelligence techniques for prediction of drug synergy in malignant diseases: Past, present, and future. | Rani P et al. | β | 2022 | β |
| A Small Molecule That Promotes Cellular Senescence Prevents Fibrogenesis and Tumorigenesis. | Meang MK et al. | β | 2022 | β |
| Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes. | Cannataro VL et al. | β | 2022 | β |
| Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. | Gimple RC et al. | β | 2022 | β |
| Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. | Saha T et al. | β | 2022 | β |
| Cancer-Associated Fibroblasts and Squamous Epithelial Cells Constitute a Unique Microenvironment in a Mouse Model of Inflammation-Induced Colon Cancer. | Vega PN et al. | β | 2022 | β |
| Cancer ego-system in glioma: an iron-replenishing niche network systemically self-organized by cancer stem cells. | Tabu K et al. | β | 2022 | β |
| Cancer evolution: Special focus on the immune aspect of cancer. | Hu X et al. | β | 2022 | β |
| Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity. | Mansouri S et al. | β | 2022 | β |
| Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment. | Kilmister EJ et al. | β | 2022 | β |
| Cancer progression as a learning process. | Shomar A et al. | β | 2022 | β |
| Cancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution. | Sepich-Poore GD et al. | β | 2022 | β |
| Causes and functional intricacies of inter- and intratumor heterogeneity of primary liver cancers. | Khatib SA et al. | β | 2022 | β |
| Cell-cell interactions that drive tumorigenesis in <i>Drosophila</i>. | Enomoto M et al. | β | 2022 | β |
| Cellular barcoding to decipher clonal dynamics in disease. | Sankaran VG et al. | β | 2022 | β |
| Chromosomal instability in adult-type diffuse gliomas. | Richardson TE et al. | β | 2022 | β |
| Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity. | van den Bosch T et al. | β | 2022 | β |
| clevRvis: visualization techniques for clonal evolution. | Sandmann S et al. | β | 2022 | β |
| Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-up. | Baak JPA et al. | β | 2022 | β |
| Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy. | Zapatka M et al. | β | 2022 | β |
| Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts. | Kuiken HJ et al. | β | 2022 | β |
| Clonal Selection and Evolution of HTLV-1-Infected Cells Driven by Genetic and Epigenetic Alteration. | Yamagishi M et al. | β | 2022 | β |
| Deciphering clonal dynamics and metastatic routines in a rare patient of synchronous triple-primary tumors and multiple metastases with MPTevol. | Chen Q et al. | β | 2022 | β |
| Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy. | Gilson P et al. | β | 2022 | β |
| Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. | Nadeu F et al. | β | 2022 | β |
| Disruption of cancer cell functions by task-specific drug perturbations. | Ahmed M et al. | β | 2022 | β |
| Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo Models. | Desai RH et al. | β | 2022 | β |
| Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia. | Guess T et al. | β | 2022 | β |
| Driver mutations in ADGRL3 are involved in the evolution of ependymoma. | Wang J et al. | β | 2022 | β |
| Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces. | Safa AR | β | 2022 | β |
| Drug-Resistant Cancer Treatment Strategies Based on the Dynamics of Clonal Evolution and PKPD Modeling of Drug Combinations. | Vakil V et al. | β | 2022 | β |
| Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers. | PeΓ±a-Romero AC et al. | β | 2022 | β |
| Dynamic Co-Evolution of Cancer Cells and Cancer-Associated Fibroblasts: Role in Right- and Left-Sided Colon Cancer Progression and Its Clinical Relevance. | Ahmad Zawawi SS et al. | β | 2022 | β |
| Embracing Project Optimus: Can we Leverage Evolutionary Theory to Optimize Dosing in Oncology? | Qi T et al. | β | 2022 | β |
| Epigenomic tumor evolution under the spotlight: the promises of single-cell approaches. | Vallot C | β | 2022 | β |
| Epistasis and evolutionary dependencies in human cancers. | Mina M et al. | β | 2022 | β |
| Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity. | Zheng P et al. | β | 2022 | β |
| Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything. | Kader T et al. | β | 2022 | β |
| Evo-devo perspectives on cancer. | Nedelcu AM | β | 2022 | β |
| Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. | Schmidt M et al. | β | 2022 | β |
| Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present. | Achimas-Cadariu P et al. | β | 2022 | β |
| Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma. | Affinito O et al. | β | 2022 | β |
| Extrinsic cell death pathway plasticity: a driver of clonal evolution in cancer? | Seidel E et al. | β | 2022 | β |
| Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure. | Vellichirammal NN et al. | β | 2022 | β |
| Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors. | Kang M et al. | β | 2022 | β |
| Gene-Mutation-Based Algorithm for Prediction of Treatment Response in Colorectal Cancer Patients. | Johnson H et al. | β | 2022 | β |
| Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia. | Petti AA et al. | β | 2022 | β |
| Genome chaos: Creating new genomic information essential for cancer macroevolution. | Heng J et al. | β | 2022 | β |
| Genomic heterogeneity as a barrier to precision oncology in urothelial cancer. | Clinton TN et al. | β | 2022 | β |
| Hallmarks of cancer and hallmarks of aging. | Blagosklonny MV | β | 2022 | β |
| Identification, Culture and Targeting of Cancer Stem Cells. | Herreros-Pomares A | β | 2022 | β |
| Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets. | Hu C et al. | β | 2022 | β |
| Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma. | Chen R et al. | β | 2022 | β |
| Impact of cancer evolution on immune surveillance and checkpoint inhibitor response. | Wu Y et al. | β | 2022 | β |
| Inferring parameters of cancer evolution in chronic lymphocytic leukemia. | Lee ND et al. | β | 2022 | β |
| Integrating mutational and nonmutational mechanisms of acquired therapy resistance within the Darwinian paradigm. | Vander Velde R et al. | β | 2022 | β |
| Integration of multiple lineage measurements from the same cell reconstructs parallel tumor evolution. | Kester L et al. | β | 2022 | β |
| J-SPACE: a Julia package for the simulation of spatial models of cancer evolution and of sequencing experiments. | Angaroni F et al. | β | 2022 | β |
| KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity. | Fournier M et al. | β | 2022 | β |
| Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers. | Bowes AL et al. | β | 2022 | β |
| Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution. | Yang D et al. | β | 2022 | β |
| Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand? | Perge P et al. | β | 2022 | β |
| LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells. | Fan B et al. | β | 2022 | β |
| Mapping Phenotypic Plasticity upon the Cancer Cell State Landscape Using Manifold Learning. | Burkhardt DB et al. | β | 2022 | β |
| Mathematical modeling for mutator phenotype and clonal selection advantage in the risk analysis of lung cancer. | Li L et al. | β | 2022 | β |
| Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). | Atkins MB et al. | β | 2022 | β |
| Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer. | Dong Y et al. | β | 2022 | β |
| Metabolic reprogramming: a bridge between aging and tumorigenesis. | Drapela S et al. | β | 2022 | β |
| Metabolomics in High Grade Gliomas. | Yu N et al. | β | 2022 | β |
| Methylation Profiling in Diffuse Gliomas: Diagnostic Value and Considerations. | Wenger A et al. | β | 2022 | β |
| Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm. | Gaulin C et al. | β | 2022 | β |
| Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer. | MajernΓk M et al. | β | 2022 | β |
| Multistate models for the natural history of cancer progression. | Cheung LC et al. | β | 2022 | β |
| Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research. | Zhu S et al. | β | 2022 | β |
| New classification for advanced breast cancer patients experiencing disease progression during salvage treatment: a single-center retrospective cohort study. | Wen J et al. | β | 2022 | β |
| Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia. | De Santis S et al. | β | 2022 | β |
| Pan-cancer surveys indicate cell cycle-related roles of primate-specific genes in tumors and embryonic cerebrum. | Ma C et al. | β | 2022 | β |
| Parsimonious Clone Tree Integration in cancer. | Sashittal P et al. | β | 2022 | β |
| Phenotypic, genomic, and transcriptomic heterogeneity in a pancreatic cancer cell line | Xie G et al. | β | 2022 | β |
| Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity. | Schwarz FM et al. | β | 2022 | β |
| Population genetics of clonally transmissible cancers. | NΓ Leathlobhair M et al. | β | 2022 | β |
| Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm. | Pallikonda HA et al. | β | 2022 | β |
| Predictive validity in drug discovery: what it is, why it matters and how to improve it. | Scannell JW et al. | β | 2022 | β |
| Prognostic Value of Molecular Intratumor Heterogeneity in Primary Oral Cancer and Its Lymph Node Metastases Assessed by Mass Spectrometry Imaging. | Kurczyk A et al. | β | 2022 | β |
| Promotion of tumor progression by exosome transmission of circular RNA circSKA3. | Du WW et al. | β | 2022 | β |
| Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes. | Somarelli JA et al. | β | 2022 | β |
| Reconstructing tumor clonal lineage trees incorporating single-nucleotide variants, copy number alterations and structural variations. | Fu X et al. | β | 2022 | β |
| Regulatory RNAs, microRNA, long-non coding RNA and circular RNA roles in colorectal cancer stem cells. | Chao HM et al. | β | 2022 | β |
| Scales of Cancer Evolution: Selfish Genome or Cooperating Cells? | BrutovskΓ½ B | β | 2022 | β |
| SCClone: Accurate Clustering of Tumor Single-Cell DNA Sequencing Data. | Yu Z et al. | β | 2022 | β |
| Scelestial: Fast and accurate single-cell lineage tree inference based on a Steiner tree approximation algorithm. | Foroughmand-Araabi MH et al. | β | 2022 | β |
| Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor. | Singh B et al. | β | 2022 | β |
| Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection. | Cani AK et al. | β | 2022 | β |
| Signaling pathways in the regulation of cancer stem cells and associated targeted therapy. | Manni W et al. | β | 2022 | β |
| Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses. | Liu Y et al. | β | 2022 | β |
| Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. | Huang Z et al. | β | 2022 | β |
| Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistance. | Rosati D et al. | β | 2022 | β |
| Solute exchange through gap junctions lessens the adverse effects of inactivating mutations in metabolite-handling genes. | Monterisi S et al. | β | 2022 | β |
| Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes. | Lobon I et al. | β | 2022 | β |
| Somatic variation in normal tissues: friend or foe of cancer early detection? | Acha-Sagredo A et al. | β | 2022 | β |
| Spatial genomics maps the structure, nature and evolution of cancer clones. | Lomakin A et al. | β | 2022 | β |
| Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors. | Lou X et al. | β | 2022 | β |
| Stochastic Fluctuations Drive Non-genetic Evolution of Proliferation in Clonal Cancer Cell Populations. | Ortega-Sabater C et al. | β | 2022 | β |
| Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects. | Gangwar SK et al. | β | 2022 | β |
| TEAD4 overexpression suppresses thyroid cancer progression and metastasis <i>in vitro</i> by modulating Wnt signaling. | Zhang B et al. | β | 2022 | β |
| Telomere Maintenance and the cGAS-STING Pathway in Cancer. | Ebata H et al. | β | 2022 | β |
| The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients. | Kahl I et al. | β | 2022 | β |
| The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1. | Borde C et al. | β | 2022 | β |
| The evolution and ecology of benign tumors. | Boutry J et al. | β | 2022 | β |
| The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Alhaddad L et al. | β | 2022 | β |
| Therapy-induced polyploidization and senescence: Coincidence or interconnection? | Sikora E et al. | β | 2022 | β |
| Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution. | Thol K et al. | β | 2022 | β |
| The translational challenges of precision oncology. | Pich O et al. | β | 2022 | β |
| The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies. | Gezer U et al. | β | 2022 | β |
| Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness. | Sengupta S et al. | β | 2022 | β |
| Tumour immunotherapy: lessons from predator-prey theory. | Hamilton PT et al. | β | 2022 | β |
| Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis. | Hamdan A et al. | β | 2022 | β |
| Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy. | Bai X et al. | β | 2022 | β |
| Unravelling undifferentiated soft tissue sarcomas: insights from genomics. | Hames-Fathi S et al. | β | 2022 | β |
| Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor. | Chen B et al. | β | 2022 | β |
| Wnt/Ξ²-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. | Leung RWH et al. | β | 2022 | β |
| Yeast-based evolutionary modeling of androgen receptor mutations and natural selection. | Zhang H et al. | β | 2022 | β |
| Zebrafish imaging reveals TP53 mutation switching oncogene-induced senescence from suppressor to driver in primary tumorigenesis. | Haraoka Y et al. | β | 2022 | β |
| A BAYESIAN NONPARAMETRIC MODEL FOR INFERRING SUBCLONAL POPULATIONS FROM STRUCTURED DNA SEQUENCING DATA. | He S et al. | β | 2021 | β |
| A common methodological phylogenomics framework for intra-patient heteroplasmies to infer SARS-CoV-2 sublineages and tumor clones. | Utro F et al. | β | 2021 | β |
| Acquisition of cancer stem cell capacities after spontaneous cell fusion. | Merle C et al. | β | 2021 | β |
| Adipose-derived stem/stromal cell secretome modulates breast cancer cell proliferation and differentiation state towards aggressiveness. | de Miranda MC et al. | β | 2021 | β |
| Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer. | Qi M et al. | β | 2021 | β |
| A large-scale snapshot of intratumor heterogeneity in human cancer. | Ju YS | β | 2021 | β |
| Alternative models of cancer stem cells: The stemness phenotype model, 10 years later. | Kaushik V et al. | β | 2021 | β |
| Analysis and Interpretation of the Impact of Missense Variants in Cancer. | Petrosino M et al. | β | 2021 | β |
| A narrative review of tumor heterogeneity and challenges to tumor drug therapy. | Zhu L et al. | β | 2021 | β |
| An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields. | Beyes S et al. | β | 2021 | β |
| An evolutionary approach to clonally complex hematologic disorders. | Schwenger E et al. | β | 2021 | β |
| An integrative analysis of the age-associated multi-omic landscape across cancers. | Chatsirisupachai K et al. | β | 2021 | β |
| An interplay of resource availability, population size and mutation rate potentiates the evolution of metabolic signaling. | Kumawat B et al. | β | 2021 | β |
| An Update on the Effects of Probiotics on Gastrointestinal Cancers. | Davoodvandi A et al. | β | 2021 | β |
| A practical guide to cancer subclonal reconstruction from DNA sequencing. | Tarabichi M et al. | β | 2021 | β |
| A rapid CRISPR competitive assay for <i>in vitro</i> and <i>in vivo</i> discovery of potential drug targets affecting the hematopoietic system. | Shen Y et al. | β | 2021 | β |
| A Reliable Prognostic Model for HCC Using Histological Grades and the Expression Levels of Related Genes. | Zhang H et al. | β | 2021 | β |
| Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms race. | Ibrahim-Hashim A et al. | β | 2021 | β |
| Assessing the contribution of tumor mutational phenotypes to cancer progression risk. | Tao Y et al. | β | 2021 | β |
| A statistical approach for tracking clonal dynamics in cancer using longitudinal next-generation sequencing data. | Vavoulis DV et al. | β | 2021 | β |
| A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC. | Gopalan V et al. | β | 2021 | β |
| Bioinformatic approaches to the investigation of the atavistic genes implicated in cancer. | Louka A et al. | β | 2021 | β |
| Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer. | Pechlivanis M et al. | β | 2021 | β |
| Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. | LΓΌΓΆnd F et al. | β | 2021 | β |
| Bridging Tumorigenesis and Therapy Resistance With a Non-Darwinian and Non-Lamarckian Mechanism of Adaptive Evolution. | Catania F et al. | β | 2021 | β |
| Cancer as a form of life: Musings of the cancer and evolution symposium. | Paul D | β | 2021 | β |
| CancerEMC: frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA. | Rahaman S et al. | β | 2021 | β |
| Cancer evolution: A means by which tumors evade treatment. | Zhu X et al. | β | 2021 | β |
| Cancer evolution: Darwin and beyond. | Vendramin R et al. | β | 2021 | β |
| Cancer <i>Evo-Dev</i>: A Theory of Inflammation-Induced Oncogenesis. | Liu W et al. | β | 2021 | β |
| Cancer immunoediting: A game theoretical approach. | Tavakoli F et al. | β | 2021 | β |
| Cancer metabolism and intervention therapy. | Zhao H et al. | β | 2021 | β |
| Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. | Aramini B et al. | β | 2021 | β |
| Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy. | Kaur J et al. | β | 2021 | β |
| CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner. | Zhu Z et al. | β | 2021 | β |
| Cell competition in intratumoral and tumor microenvironment interactions. | Parker TM et al. | β | 2021 | β |
| Cellular heterogeneity and microenvironmental control of skin cancer. | Lichtenberger BM et al. | β | 2021 | β |
| Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. | Dentro SC et al. | β | 2021 | β |
| Clinical analysis of 117 cases with synchronous multiple primary esophageal squamous cell carcinomas. | Chen Z et al. | β | 2021 | β |
| Clinical cancer genomic profiling. | Chakravarty D et al. | β | 2021 | β |
| Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias. | Duchmann M et al. | β | 2021 | β |
| Clonal Architecture of <i>EGFR</i> Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641). | Ai X et al. | β | 2021 | β |
| Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications. | Salomon-PerzyΕski A et al. | β | 2021 | β |
| CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data. | AbΓ©cassis J et al. | β | 2021 | β |
| Coalescent models derived from birth-death processes. | Crespo FF et al. | β | 2021 | β |
| Collapse of Intra-Tumor Cooperation Induced by Engineered Defector Cells. | Archetti M | β | 2021 | β |
| Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy. | Balikov DA et al. | β | 2021 | β |
| Conifer: clonal tree inference for tumor heterogeneity with single-cell and bulk sequencing data. | Baghaarabani L et al. | β | 2021 | β |
| Cooperation of partially-transformed clones: an invisible force behind the early stages of carcinogenesis. | Esposito A | β | 2021 | β |
| Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy. | Ishitsuka Y et al. | β | 2021 | β |
| DeCiFering the elusive cancer cell fraction in tumor heterogeneity and evolution. | Satas G et al. | β | 2021 | β |
| Delineating the longitudinal tumor evolution using organoid models. | Lu Z et al. | β | 2021 | β |
| Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer. | Zhuang Z et al. | β | 2021 | β |
| DEVOLUTION-A method for phylogenetic reconstruction of aneuploid cancers based on multiregional genotyping data. | Andersson N et al. | β | 2021 | β |
| Dissecting single-cell genomes through the clonal organoid technique. | Youk J et al. | β | 2021 | β |
| Distinguishing linear and branched evolution given single-cell DNA sequencing data of tumors. | Weber LL et al. | β | 2021 | β |
| DNA damage in cancer development: special implications in viral oncogenesis. | Katerji M et al. | β | 2021 | β |
| DNA methylation patterns of RAR-Ξ²2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions. | Kougioumtsidou N et al. | β | 2021 | β |
| Dosage strategies for delaying resistance emergence in heterogeneous tumors. | Vakil V et al. | β | 2021 | β |
| Effective Clustering for Single Cell Sequencing Cancer Data. | Ciccolella S et al. | β | 2021 | β |
| Elements and evolutionary determinants of genomic divergence between paired primary and metastatic tumors. | Sun R et al. | β | 2021 | β |
| Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells. | Mandhair HK et al. | β | 2021 | β |
| Epigenome Chaos: Stochastic and Deterministic DNA Methylation Events Drive Cancer Evolution. | Russo G et al. | β | 2021 | β |
| Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches. | Balzerano A et al. | β | 2021 | β |
| Exact site frequency spectra of neutrally evolving tumors: A transition between power laws reveals a signature of cell viability. | Gunnarsson EB et al. | β | 2021 | β |
| Exosomes and Cancer Stem Cells in Cancer Immunity: Current Reports and Future Directions. | Lee NK et al. | β | 2021 | β |
| Extreme value theory as a framework for understanding mutation frequency distribution in cancer genomes. | Tokutomi N et al. | β | 2021 | β |
| From DNA damage to mutations: All roads lead to aging. | Vijg J | β | 2021 | β |
| Future Match Making: When Pediatric Oncology Meets Organoid Technology. | Barbet V et al. | β | 2021 | β |
| Gene Duplication and Gene Fusion Are Important Drivers of Tumourigenesis during Cancer Evolution. | Glenfield C et al. | β | 2021 | β |
| Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis. | Motwani J et al. | β | 2021 | β |
| Genetic and non-genetic clonal diversity in cancer evolution. | Black JRM et al. | β | 2021 | β |
| Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution. | Shlyakhtina Y et al. | β | 2021 | β |
| Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity. | Caruso S et al. | β | 2021 | β |
| Genome and metabolome: chance and necessity. | GonΓ§alves E et al. | β | 2021 | β |
| Genome Instability in Multiple Myeloma: Facts and Factors. | Aksenova AY et al. | β | 2021 | β |
| Genome profiles of pathologist-defined cell clusters by multiregional LCM and G&T-seq in one triple-negative breast cancer patient. | Zhu Z et al. | β | 2021 | β |
| Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges. | Piper K et al. | β | 2021 | β |
| Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies. | Harland A et al. | β | 2021 | β |
| GRMT: Generative Reconstruction of Mutation Tree From Scratch Using Single-Cell Sequencing Data. | Yu Z et al. | β | 2021 | β |
| Harnessing Mitochondrial Mutations to ATAC Clonal Evolution in CLL. | Hilton LK et al. | β | 2021 | β |
| Identification of Cell Surface Molecules That Determine the Macrophage Activation Threshold Associated With an Early Stage of Malignant Transformation. | Jacqueline C et al. | β | 2021 | β |
| Identifying key questions in the ecology and evolution of cancer. | Dujon AM et al. | β | 2021 | β |
| Immunity beyond cancer cells: perspective from tumor tissue. | Gao S et al. | β | 2021 | β |
| Improving cancer treatments via dynamical biophysical models. | Kuznetsov M et al. | β | 2021 | β |
| Induced pluripotent stem cell models of myeloid malignancies and clonal evolution. | Reilly A et al. | β | 2021 | β |
| Inferring Copy Number from Triple-Negative Breast Cancer Patient Derived Xenograft scRNAseq Data Using scCNA. | Kuzmin E et al. | β | 2021 | β |
| Intratumor Epigenetic Heterogeneity-A Panel Gene Methylation Study in Thyroid Cancer. | Zhu C et al. | β | 2021 | β |
| Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis. | Yu T et al. | β | 2021 | β |
| Intra-Tumor Heterogeneity Revealed by Mass Spectrometry Imaging Is Associated with the Prognosis of Breast Cancer. | Gawin M et al. | β | 2021 | β |
| Is cancer a disease set up by cellular stress responses? | Aranda-Anzaldo A et al. | β | 2021 | β |
| Joint Clustering of Single-Cell Sequencing and Fluorescence In Situ Hybridization Data for Reconstructing Clonal Heterogeneity in Cancers. | Fu X et al. | β | 2021 | β |
| Karyotype Aberrations in Action: The Evolution of Cancer Genomes and the Tumor Microenvironment. | Baudoin NC et al. | β | 2021 | β |
| Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response. | Georgopoulou D et al. | β | 2021 | β |
| Limited evolution of the actionable metastatic cancer genome under therapeutic pressure. | van de Haar J et al. | β | 2021 | β |
| Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy. | Zheng X et al. | β | 2021 | β |
| Liver cancer stem cells: Recent progress in basic and clinical research. | Yamashita T et al. | β | 2021 | β |
| MEDALT: single-cell copy number lineage tracing enabling gene discovery. | Wang F et al. | β | 2021 | β |
| Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going? | Varrone F et al. | β | 2021 | β |
| Melanoma Single-Cell Biology in Experimental and Clinical Settings. | Binder H et al. | β | 2021 | β |
| Modeling colorectal cancer evolution. | Niida A et al. | β | 2021 | β |
| Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients. | Puccini A et al. | β | 2021 | β |
| Molecular Genetics in Neuroblastoma Prognosis. | Lerone M et al. | β | 2021 | β |
| More Than Meets the Eye Regarding Cancer Metabolism. | Kubicka A et al. | β | 2021 | β |
| Moss enables high sensitivity single-nucleotide variant calling from multiple bulk DNA tumor samples. | Zhang C et al. | β | 2021 | β |
| Multi-color clonal tracking reveals intra-stage proliferative heterogeneity during mammary tumor progression. | Tiede S et al. | β | 2021 | β |
| Multifunctional Role of Astrocyte Elevated Gene-1 (AEG-1) in Cancer: Focus on Drug Resistance. | Manna D et al. | β | 2021 | β |
| Multiple Myeloma: Molecular Pathogenesis and Disease Evolution. | Heider M et al. | β | 2021 | β |
| Multiregion Sequence Analysis to Predict Intratumor Heterogeneity and Clonal Evolution. | Ahn S et al. | β | 2021 | β |
| Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine. | RΓΆcken C et al. | β | 2021 | β |
| Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of <i>CCND1</i>/<i>CDK4</i>/<i>PLK1</i>/<i>CD44</i> in Cancer Types. | Mokgautsi N et al. | β | 2021 | β |
| New strategies for managing adult gliomas. | Kirby AJ et al. | β | 2021 | β |
| Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents. | Singh T et al. | β | 2021 | β |
| On the role of p53 in the cellular response to aneuploidy. | Narkar A et al. | β | 2021 | β |
| Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship. | Pandkar MR et al. | β | 2021 | β |
| Pancreatic cancer pathology viewed in the light of evolution. | NoΓ« M et al. | β | 2021 | β |
| Paracrine Behaviors Arbitrate Parasite-Like Interactions Between Tumor Subclones. | Noble RJ et al. | β | 2021 | β |
| Pathfinders in oncology from the time the causal relation between tobacco use and lung cancer was established to publication of the first Cancer Staging Manual by the American Joint Committee on Cancer. | Hajdu SI | β | 2021 | β |
| Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model. | Horst EN et al. | β | 2021 | β |
| Phospholipase A<sub>2</sub> Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1. | Vecchi L et al. | β | 2021 | β |
| Phycocyanin from <i>Arthrospira platensis</i> as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies. | Braune S et al. | β | 2021 | β |
| PhyliCS: a Python library to explore scCNA data and quantify spatial tumor heterogeneity. | Montemurro M et al. | β | 2021 | β |
| Phylodynamics for cell biologists. | Stadler T et al. | β | 2021 | β |
| Place des biopsies liquides dans le diagnostic et la caractΓ©risation molΓ©culaire des cancers du sein: Role of liquid biopsies in the diagnosis and molecular characterization of breast cancer. | Vion R et al. | β | 2021 | β |
| Plasticity in Colorectal Cancer: Why Cancer Cells Differentiate. | Walter RJ et al. | β | 2021 | β |
| PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineage. | Zhang Y et al. | β | 2021 | β |
| Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed. | Pfohl U et al. | β | 2021 | β |
| [Progress in clonal evolution of multiple myeloma]. | Wang Y et al. | β | 2021 | β |
| Progression signature underlies clonal evolution and dissemination of multiple myeloma. | Shen YJ et al. | β | 2021 | β |
| RDAClone: Deciphering Tumor Heterozygosity through Single-Cell Genomics Data Analysis with Robust Deep Autoencoder. | Xia J et al. | β | 2021 | β |
| RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models. | Gambera S et al. | β | 2021 | β |
| Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment. | Yang Y et al. | β | 2021 | β |
| Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma. | de Lange MJ et al. | β | 2021 | β |
| Selection-driven tumor evolution with public goods leads to patterns of clonal expansion consistent with neutral growth. | Edwards J et al. | β | 2021 | β |
| Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets. | Wang T et al. | β | 2021 | β |
| Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. | Ma L et al. | β | 2021 | β |
| Single-cell DNA and RNA sequencing reveals the dynamics of intra-tumor heterogeneity in a colorectal cancer model. | Ono H et al. | β | 2021 | β |
| Single-Cell Landscape of Liver Cancer in Response to Immunotherapy. | Diao F | β | 2021 | β |
| Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. | Quinn JJ et al. | β | 2021 | β |
| Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs. | Cheng H et al. | β | 2021 | β |
| Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma. | Moore AL et al. | β | 2021 | β |
| STARCH: copy number and clone inference from spatial transcriptomics data. | Elyanow R et al. | β | 2021 | β |
| Struggle within: evolution and ecology of somatic cell populations. | Swiatczak B | β | 2021 | β |
| Studying the History of Tumor Evolution from Single-Cell Sequencing Data by Exploring the Space of Binary Matrices. | MalikiΔ S et al. | β | 2021 | β |
| Subclonal heterogeneity and evolution in breast cancer. | Mavrommati I et al. | β | 2021 | β |
| Suv420 enrichment at the centromere limits Aurora B localization and function. | Herlihy CP et al. | β | 2021 | β |
| Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. | Vitale I et al. | β | 2021 | β |
| Targeting Glioma Stem Cells. | Muftuoglu Y et al. | β | 2021 | β |
| Targeting loss of heterozygosity for cancer-specific immunotherapy. | Hwang MS et al. | β | 2021 | β |
| Targeting the genetic landscape of oral potentially malignant disorders has the potential as a preventative strategy in oral cancer. | Prime SS et al. | β | 2021 | β |
| The Bourque distances for mutation trees of cancers. | Jahn K et al. | β | 2021 | β |
| The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status. | Pustovalova M et al. | β | 2021 | β |
| The Concept of "Cancer Stem Cells" in the Context of Classic Carcinogenesis Hypotheses and Experimental Findings. | Trosko JE | β | 2021 | β |
| The Occurrence of Malignancy in <i>Trypanosoma brucei brucei</i> by Rapid Passage in Mice. | Cai XL et al. | β | 2021 | β |
| The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks. | DemΓ©ny MA et al. | β | 2021 | β |
| The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas. | Garcia-Lacarte M et al. | β | 2021 | β |
| The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. | Patil K et al. | β | 2021 | β |
| The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC. | Tamiya M et al. | β | 2021 | β |
| The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas. | Yekula A et al. | β | 2021 | β |
| The role of the DFF40/CAD endonuclease in genomic stability. | Kulbay M et al. | β | 2021 | β |
| The 'Yin and Yang' of Cancer Cell Growth and Mechanosensing. | Amer M et al. | β | 2021 | β |
| Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution. | Ma L et al. | β | 2021 | β |
| Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches. | Lee D et al. | β | 2021 | β |
| Tracking Cancer Evolution through the Disease Course. | Bailey C et al. | β | 2021 | β |
| Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq. | Vishnubalaji R et al. | β | 2021 | β |
| Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer. | Ionkina AA et al. | β | 2021 | β |
| Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy. | El-Sayes N et al. | β | 2021 | β |
| Tumor heterogeneity assessed by sequencing and fluorescence in situ hybridization (FISH) data. | Lei H et al. | β | 2021 | β |
| Tumors Are Evolutionary Island-Like Ecosystems. | Chroni A et al. | β | 2021 | β |
| Two-phased evolution: Genome chaos-mediated information creation and maintenance. | Heng J et al. | β | 2021 | β |
| Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment. | Pasha N et al. | β | 2021 | β |
| Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis. | Heinrich S et al. | β | 2021 | β |
| Unraveling Tumor Heterogeneity by Using DNA Barcoding Technologies to Develop Personalized Treatment Strategies in Advanced-Stage PDAC. | Dujardin P et al. | β | 2021 | β |
| Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer. | Chao JY et al. | β | 2021 | β |
| Using single-cell sequencing technology to detect circulating tumor cells in solid tumors. | Xu J et al. | β | 2021 | β |
| What do cellular responses to acidity tell us about cancer? | Blaszczak W et al. | β | 2021 | β |
| Wnt/Ξ²-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways. | Deldar Abad Paskeh M et al. | β | 2021 | β |
| Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications. | Lin L et al. | β | 2020 | β |
| Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data. | Zaccaria S et al. | β | 2020 | β |
| A compartment size-dependent selective threshold limits mutation accumulation in hierarchical tissues. | Grajzel D et al. | β | 2020 | β |
| Adipose-derived stem cells and cancer cells fuse to generate cancer stem cell-like cells with increased tumorigenicity. | Chan YW et al. | β | 2020 | β |
| ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo. | Nagare RP et al. | β | 2020 | β |
| ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer. | Kawakami R et al. | β | 2020 | β |
| Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. | Costea T et al. | β | 2020 | β |
| A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries. | Fiore D et al. | β | 2020 | β |
| Assessing Cell Activities rather than Identities to Interpret Intra-Tumor Phenotypic Diversity and Its Dynamics. | Monteiro L et al. | β | 2020 | β |
| Assessing the performance of methods for copy number aberration detection from single-cell DNA sequencing data. | Mallory XF et al. | β | 2020 | β |
| Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study. | Kawachi H et al. | β | 2020 | β |
| A unified simulation model for understanding the diversity of cancer evolution. | Niida A et al. | β | 2020 | β |
| Automated spheroid generation, drug application and efficacy screening using a deep learning classification: a feasibility study. | Benning L et al. | β | 2020 | β |
| Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning. | Miao R et al. | β | 2020 | β |
| Biophysical and epigenetic regulation of cancer stemness, invasiveness and immune action. | Veerasubramanian PK et al. | β | 2020 | β |
| Breast cancer stem cells: A fallow research ground in Africa. | Gyan E et al. | β | 2020 | β |
| C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma. | Luo SQ et al. | β | 2020 | β |
| Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. | Guo SW | β | 2020 | β |
| Cancer Cell Acid Adaptation Gene Expression Response Is Correlated to Tumor-Specific Tissue Expression Profiles and Patient Survival. | Yao J et al. | β | 2020 | β |
| Cancer cell lines show high heritability for motility but not generation time. | Wass AV et al. | β | 2020 | β |
| Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity. | Al-Sowayan BS et al. | β | 2020 | β |
| Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. | Liu YC et al. | β | 2020 | β |
| Cancer stem cell plasticity in glioblastoma multiforme: a perspective on future directions in oncolytic virotherapy. | Kim DS | β | 2020 | β |
| Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis. | CeliΓ -Terrassa T et al. | β | 2020 | β |
| Cancer Stemness: p53 at the Wheel. | Ghatak D et al. | β | 2020 | β |
| Can Environmental Manipulation Help Suppress Cancer? Non-Linear Competition Among Tumor Cells in Periodically Changing Conditions. | Babajanyan SG et al. | β | 2020 | β |
| Cell competition and tumor heterogeneity. | Parker TM et al. | β | 2020 | β |
| Characterizing the ecological and evolutionary dynamics of cancer. | Zahir N et al. | β | 2020 | β |
| Clonal evolution driven by superdriver mutations. | Grossmann P et al. | β | 2020 | β |
| Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. | Jaiswal S et al. | β | 2020 | β |
| ClonArch: visualizing the spatial clonal architecture of tumors. | Wu J et al. | β | 2020 | β |
| Clone Wars: Quantitatively Understanding Cancer Drug Resistance. | Yates JWT et al. | β | 2020 | β |
| Comparative Molecular Life History of Spontaneous Canine and Human Gliomas. | Amin SB et al. | β | 2020 | β |
| Comparing copy-number profiles under multi-copy amplifications and deletions. | Cordonnier G et al. | β | 2020 | β |
| Context-dependent selection as the keystone in the somatic evolution of cancer. | Vibishan B et al. | β | 2020 | β |
| Copy number evolution with weighted aberrations in cancer. | Zeira R et al. | β | 2020 | β |
| Cytologic and Molecular Diagnostics for Vitreoretinal Lymphoma: Current Approaches and Emerging Single-Cell Analyses. | Tan WJ et al. | β | 2020 | β |
| Distance measures for tumor evolutionary trees. | DiNardo Z et al. | β | 2020 | β |
| Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review. | Filip S et al. | β | 2020 | β |
| DNA damage in colon mucosa of Pirc rats, an Apc-driven model of colon tumorigenesis. | Tortora K et al. | β | 2020 | β |
| Dynamic Signatures of the Epigenome: Friend or Foe? | Machnik M et al. | β | 2020 | β |
| Eco-oncology: Applying ecological principles to understand and manage cancer. | Reynolds BA et al. | β | 2020 | β |
| Epiclomal: Probabilistic clustering of sparse single-cell DNA methylation data. | P E de Souza C et al. | β | 2020 | β |
| Estimating growth patterns and driver effects in tumor evolution from individual samples. | Salichos L et al. | β | 2020 | β |
| Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology. | Dou X et al. | β | 2020 | β |
| Evolution of Lung Cancer in the Context of Immunotherapy. | Yu S et al. | β | 2020 | β |
| Evolving insights: how DNA repair pathways impact cancer evolution. | Zhou J et al. | β | 2020 | β |
| Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions. | Kreidieh M et al. | β | 2020 | β |
| Exploiting Cancer Cells Metabolic Adaptability to Enhance Therapy Response in Cancer. | Nunes SC | β | 2020 | β |
| Exploiting the circuit breaker cancer evolution model in human clear cell renal cell carcinoma. | Hsieh JJ et al. | β | 2020 | β |
| Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting. | Vieira de Castro J et al. | β | 2020 | β |
| Extracellular Vesicle-Based Communication May Contribute to the Co-Evolution of Cancer Stem Cells and Cancer-Associated Fibroblasts in Anti-Cancer Therapy. | Valcz G et al. | β | 2020 | β |
| FastClone is a probabilistic tool for deconvoluting tumor heterogeneity in bulk-sequencing samples. | Xiao Y et al. | β | 2020 | β |
| Gastrointestinal cancer stem cells as targets for innovative immunotherapy. | Chivu-Economescu M et al. | β | 2020 | β |
| Genetic and epigenetic determinants of diffuse large B-cell lymphoma. | Bakhshi TJ et al. | β | 2020 | β |
| Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models. | Sprouffske K et al. | β | 2020 | β |
| Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer. | Ottaiano A et al. | β | 2020 | β |
| Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance. | Condoluci A et al. | β | 2020 | β |
| Genomic Variation, Evolvability, and the Paradox of Mental Illness. | Gualtieri CT | β | 2020 | β |
| Geometric regulation of histone state directs melanoma reprogramming. | Lee J et al. | β | 2020 | β |
| Global genomics project unravels cancer's complexity at unprecedented scale. | Cieslik M et al. | β | 2020 | β |
| gpps: an ILP-based approach for inferring cancer progression with mutation losses from single cell data. | Ciccolella S et al. | β | 2020 | β |
| Harnessing hypoxia as an evolutionary driver of complex multicellularity. | Hammarlund EU | β | 2020 | β |
| Heparanase and the hallmarks of cancer. | Jayatilleke KM et al. | β | 2020 | β |
| High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma. | Yang B et al. | β | 2020 | β |
| High percentage of cancer stem cells in metastatic locations; a comment on a claim "variation in cancer risk among tissues can be explained by the number of stem cell divisions". | Kamalabadi-Farahani M et al. | β | 2020 | β |
| Holistic cancer genome profiling for every patient. | Nik-Zainal S et al. | β | 2020 | β |
| Human accelerated genome regions with value in medical genetics and drug discovery. | Chu XY et al. | β | 2020 | β |
| Identifying Cell-Type Specific Genes and Expression Rules Based on Single-Cell Transcriptomic Atlas Data. | Yuan F et al. | β | 2020 | β |
| Immune biological rationales for the design of combined radio- and immunotherapies. | Hader M et al. | β | 2020 | β |
| Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma. | Liesche-Starnecker F et al. | β | 2020 | β |
| Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. | van Gastel N et al. | β | 2020 | β |
| Inferring clonal composition from multiple tumor biopsies. | Manica M et al. | β | 2020 | β |
| Inferring structural variant cancer cell fraction. | Cmero M et al. | β | 2020 | β |
| Insight updating of the molecular hallmarks in ovarian carcinoma. | Mota A et al. | β | 2020 | β |
| In Silico implementation of evolutionary paradigm in therapy design: Towards anti-cancer therapy as Darwinian process. | Brutovsky B et al. | β | 2020 | β |
| In silico pathway analysis based on chromosomal instability in breast cancer patients. | Kour A et al. | β | 2020 | β |
| Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance. | Fugazzola L et al. | β | 2020 | β |
| Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies. | Zhang Q et al. | β | 2020 | β |
| Intratumor Heterogeneity in Early Lung Adenocarcinoma. | Senosain MF et al. | β | 2020 | β |
| Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer. | Lin PC et al. | β | 2020 | β |
| Intrinsic Balance between ZEB Family Members Is Important for Melanocyte Homeostasis and Melanoma Progression. | Bruneel K et al. | β | 2020 | β |
| Involvement of Heparan Sulfate and Heparanase in Neural Development and Pathogenesis of Brain Tumors. | Xiong A et al. | β | 2020 | β |
| Joint analysis of single-cell and bulk tissue sequencing data to infer intratumor heterogeneity. | Sun W et al. | β | 2020 | β |
| Karyotypic Flexibility of the Complex Cancer Genome and the Role of Polyploidization in Maintenance of Structural Integrity of Cancer Chromosomes. | Raftopoulou C et al. | β | 2020 | β |
| Life style factors, tumor cell plasticity and cancer stem cells. | Chiodi I et al. | β | 2020 | β |
| Loss of Mitochondrial Localization of Human FANCG Causes Defective FANCJ Helicase. | K JCB et al. | β | 2020 | β |
| <sup>137</sup>Cs Ξ³ Ray and <sup>28</sup>Si Irradiation Induced Murine Hepatocellular Carcinoma Lipid Changes in Liver Assessed by MALDI-MSI Combined with Spatial Shrunken Centroid Clustering Algorithm: A Pilot Study. | Nia AM et al. | β | 2020 | β |
| Mammary Organoids and 3D Cell Cultures: Old Dogs with New Tricks. | Sumbal J et al. | β | 2020 | β |
| Mapping the spreading routes of lymphatic metastases in human colorectal cancer. | Zhang C et al. | β | 2020 | β |
| Measuring single cell divisions in human tissues from multi-region sequencing data. | Werner B et al. | β | 2020 | β |
| Mechanisms underlying genome instability mediated by formation of foldback inversions in <i>Saccharomyces cerevisiae</i>. | Li BZ et al. | β | 2020 | β |
| Metabolic Adaptations in Cancer Stem Cells. | Yadav UP et al. | β | 2020 | β |
| Metabolic rewiring in melanoma drug-resistant cells. | Bristot IJ et al. | β | 2020 | β |
| Methodological Advancements for Investigating Intra-tumoral Heterogeneity in Breast Cancer at the Bench and Bedside. | Baek M et al. | β | 2020 | β |
| Modelling cancer progression using Mutual Hazard Networks. | Schill R et al. | β | 2020 | β |
| Molecular Biology and Evolution of Cancer: From Discovery to Action. | Somarelli JA et al. | β | 2020 | β |
| Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements. | Malki A et al. | β | 2020 | β |
| Molecular Profiles of Matched Primary and Metastatic Tumor Samples Support a Linear Evolutionary Model of Breast Cancer. | Chen R et al. | β | 2020 | β |
| Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity. | Lee WC et al. | β | 2020 | β |
| Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases. | Rabbie R et al. | β | 2020 | β |
| Mutation bias within oncogene families is related to proliferation-specific codon usage. | Benisty H et al. | β | 2020 | β |
| Natural polysaccharide-incorporated hydroxyapatite as size-changeable, nuclear-targeted nanocarrier for efficient cancer therapy. | Ren X et al. | β | 2020 | β |
| Natural Selection on Exonic SNPs Shapes Allelic Expression Imbalance (AEI) Adaptability in Lung Cancer Progression. | Huang J et al. | β | 2020 | β |
| Navigating the path to distant metastasis. | Graham TA et al. | β | 2020 | β |
| Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses. | Skov V | β | 2020 | β |
| Non-genetic mechanisms of therapeutic resistance in cancer. | Marine JC et al. | β | 2020 | β |
| Novel Therapeutic Strategies for Ovarian Cancer Stem Cells. | Terraneo N et al. | β | 2020 | β |
| NRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective. | Choi EJ et al. | β | 2020 | β |
| Organotypic Modeling of the Tumor Landscape. | Haykal MM et al. | β | 2020 | β |
| Origins and Consequences of Chromosomal Instability: From Cellular Adaptation to Genome Chaos-Mediated System Survival. | Ye CJ et al. | β | 2020 | β |
| Over a century of cancer research: Inconvenient truths and promising leads. | Sonnenschein C et al. | β | 2020 | β |
| Pathogenic Mechanisms of Somatic Mutation and Genome Mosaicism in Aging. | Vijg J et al. | β | 2020 | β |
| Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance. | Irurzun-Arana I et al. | β | 2020 | β |
| Phase and context shape the function of composite oncogenic mutations. | Gorelick AN et al. | β | 2020 | β |
| Phenotypic Heterogeneity in Tumor Progression, and Its Possible Role in the Onset of Cancer. | Deshmukh S et al. | β | 2020 | β |
| PhyDOSE: Design of follow-up single-cell sequencing experiments of tumors. | Weber LL et al. | β | 2020 | β |
| Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance. | Das PK et al. | β | 2020 | β |
| Post-transcriptional regulation of Rad51c by miR-222 contributes cellular transformation. | Rojas E et al. | β | 2020 | β |
| Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer. | Aust S et al. | β | 2020 | β |
| Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data. | Baek B et al. | β | 2020 | β |
| Pretreatment age and serum lactate dehydrogenase as predictors of synchronous second primary cancer in patients with nasopharyngeal carcinoma. | Yeh CF et al. | β | 2020 | β |
| Principles and mechanisms of non-genetic resistance in cancer. | Bell CC et al. | β | 2020 | β |
| Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site. | Nasrollahzadeh E et al. | β | 2020 | β |
| Punctuated Aneuploidization of the Budding Yeast Genome. | Heasley LR et al. | β | 2020 | β |
| PyClone-VI: scalable inference of clonal population structures using whole genome data. | Gillis S et al. | β | 2020 | β |
| Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk. | Harris KL et al. | β | 2020 | β |
| Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization. | Fanelli GN et al. | β | 2020 | β |
| Recent Advances in Droplet Microfluidics. | Ding Y et al. | β | 2020 | β |
| Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. | Rubanova Y et al. | β | 2020 | β |
| Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms. | Valent P et al. | β | 2020 | β |
| Regulating tumor suppressor genes: post-translational modifications. | Chen L et al. | β | 2020 | β |
| Relevance of CTC Clusters in Breast Cancer Metastasis. | PiΓ±eiro R et al. | β | 2020 | β |
| Renaissance minds in 21st century science. | Yanai I et al. | β | 2020 | β |
| Resistance is not the end: lessons from pest management. | Whelan CJ et al. | β | 2020 | β |
| Resistance to drugs and cell death in cancer stem cells (CSCs). | Safa AR | β | 2020 | β |
| RobustClone: a robust PCA method for tumor clone and evolution inference from single-cell sequencing data. | Chen Z et al. | β | 2020 | β |
| Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia. | Pepe F et al. | β | 2020 | β |
| Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments. | Ha NT et al. | β | 2020 | β |
| Salinomycin and dichloroacetate synergistically inhibit Lewis lung carcinoma cell proliferation, tumor growth and metastasis. | SkeberdytΔ A et al. | β | 2020 | β |
| Secondary Metabolites from the Culture of the Marine-derived Fungus <i>Paradendryphiella salina</i> PC 362H and Evaluation of the Anticancer Activity of Its Metabolite Hyalodendrin. | Dezaire A et al. | β | 2020 | β |
| Single-cell analysis based dissection of clonality in myelofibrosis. | Mylonas E et al. | β | 2020 | β |
| Statistical Inference for the Evolutionary History of Cancer Genomes. | Dinh KN et al. | β | 2020 | β |
| Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives. | Elkhenany H et al. | β | 2020 | β |
| Stratification Using hTERT and Stem Cell Markers Confers a Good Prognosis in Invasive Breast Cancer. | Wazir U et al. | β | 2020 | β |
| Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism. | Ruhnau J et al. | β | 2020 | β |
| Targeting Subventricular Zone Progenitor Cells with Intraventricular Liposomal Encapsulated Cytarabine in Patients with Secondary Glioblastoma : A Report of Two Cases. | Frankel BM et al. | β | 2020 | β |
| The Effect of Nanosystems on ATP-Binding Cassette Transporters: Understanding the Influence of Nanosystems on Multidrug Resistance Protein-1 and P-glycoprotein. | Mello FVC et al. | β | 2020 | β |
| The evolutionary history of 2,658 cancers. | Gerstung M et al. | β | 2020 | β |
| The genomic landscape of metastasis in treatment-naΓ―ve breast cancer models. | Ross C et al. | β | 2020 | β |
| The issues with tissues: the wide range of cell fate separation enables the evolution of multicellularity and cancer. | Hammarlund EU et al. | β | 2020 | β |
| The KEAP1/NRF2 Signaling Pathway in Keratinization. | Ishitsuka Y et al. | β | 2020 | β |
| The landscape of gene mutations in cirrhosis and hepatocellular carcinoma. | MΓΌller M et al. | β | 2020 | β |
| The "life code": A theory that unifies the human life cycle and the origin of human tumors. | Liu J | β | 2020 | β |
| The miRNAs Role in Melanoma and in Its Resistance to Therapy. | Varrone F et al. | β | 2020 | β |
| The paradox of cancer genes in non-malignant conditions: implications for precision medicine. | Adashek JJ et al. | β | 2020 | β |
| The Potential of Tumor Debulking to Support Molecular Targeted Therapies. | Oppel F et al. | β | 2020 | β |
| The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review. | Rugo HS et al. | β | 2020 | β |
| Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives. | Zahan T et al. | β | 2020 | β |
| The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells. | Hu Z et al. | β | 2020 | β |
| The three dimensions of somatic evolution: Integrating the role of genetic damage, life-history traits, and aging in carcinogenesis. | Rozhok AI et al. | β | 2020 | β |
| Towards Multidrug Adaptive Therapy. | West J et al. | β | 2020 | β |
| Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review. | Papa V et al. | β | 2020 | β |
| Tumor Copy Number Deconvolution Integrating Bulk and Single-Cell Sequencing Data. | Lei H et al. | β | 2020 | β |
| Tumor heterogeneity in muscle-invasive bladder cancer. | Kang HW et al. | β | 2020 | β |
| Tumor MicroenvironmentΒ - Selective Pressures Boosting Cancer Progression. | Nunes SC | β | 2020 | β |
| Tumor Profiling at the Service of Cancer Therapy. | Fernandez-Rozadilla C et al. | β | 2020 | β |
| Tumour evolution in hepatocellular carcinoma. | Craig AJ et al. | β | 2020 | β |
| Tumour heterogeneity and the evolutionary trade-offs of cancer. | Hausser J et al. | β | 2020 | β |
| Tyrosine Kinase Receptors in Oncology. | Esteban-Villarrubia J et al. | β | 2020 | β |
| Understanding EGFR heterogeneity in lung cancer. | Passaro A et al. | β | 2020 | β |
| Update on Fundamental Mechanisms of Thyroid Cancer. | Prete A et al. | β | 2020 | β |
| Whole-exome mutational landscape of metastasis in patient-derived hepatocellular carcinoma cells. | Zhou Q et al. | β | 2020 | β |
| Why is cancer not more common? A changing microenvironment may help to explain why, and suggests strategies for anti-cancer therapy. | Jiang X et al. | β | 2020 | β |
| Why we do what we do. A brief analysis of cancer therapies. | Galmarini CM | β | 2020 | β |
| Addressing cellular heterogeneity in tumor and circulation for refined prognostication. | Lim SB et al. | β | 2019 | β |
| Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer. | Robertson J et al. | β | 2019 | β |
| Aging and cancer: Is glucose a mediator between them? | Golubev AG et al. | β | 2019 | β |
| A multi-labeled tree dissimilarity measure for comparing "clonal trees" of tumor progression. | Karpov N et al. | β | 2019 | β |
| An analysis of genetic heterogeneity in untreated cancers. | Reiter JG et al. | β | 2019 | β |
| A Pipeline for Reconstructing Somatic Copy Number Alternation's Subclonal Population-Based Next-Generation Sequencing Data. | Chu Y et al. | β | 2019 | β |
| aPKCi triggers basal extrusion of luminal mammary epithelial cells by tuning contractility and vinculin localization at cell junctions. | Villeneuve C et al. | β | 2019 | β |
| Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data. | AbΓ©cassis J et al. | β | 2019 | β |
| Associating somatic mutations to clinical outcomes: a pan-cancer study of survival time. | Little P et al. | β | 2019 | β |
| A view on drug resistance in cancer. | Vasan N et al. | β | 2019 | β |
| BAMSE: Bayesian model selection for tumor phylogeny inference among multiple samples. | Toosi H et al. | β | 2019 | β |
| Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma. | Lin L et al. | β | 2019 | β |
| CALDER: Inferring Phylogenetic Trees from Longitudinal Tumor Samples. | Myers MA et al. | β | 2019 | β |
| Cancer-Associated Mutations but No Cancer: Insights into the Early Steps of Carcinogenesis and Implications for Early Cancer Detection. | Kennedy SR et al. | β | 2019 | β |
| Cancer: Context Is Key for E-cadherin in Invasion andΒ Metastasis. | Fearon ER | β | 2019 | β |
| Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players. | Othman N et al. | β | 2019 | β |
| Cancer Ecology and Evolution: Positive interactions and system vulnerability. | Adler FR et al. | β | 2019 | β |
| Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastoma. | Makhlin I et al. | β | 2019 | β |
| Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma. | Mao H | β | 2019 | β |
| Clonal evolution and immune evasion in posttransplantation relapses. | Vago L | β | 2019 | β |
| Clonal evolution of acute myeloid leukemia from diagnosis to relapse. | Vosberg S et al. | β | 2019 | β |
| Clonal reconstruction from time course genomic sequencing data. | Ismail WM et al. | β | 2019 | β |
| Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression. | Anttila JV et al. | β | 2019 | β |
| Current Perspectives in Cancer Immunotherapy. | Christofi T et al. | β | 2019 | β |
| Delineation of Tumor Migration Paths by Using a Bayesian Biogeographic Approach. | Chroni A et al. | β | 2019 | β |
| Developing and Validating Risk Assessment Models of Clinical Outcomes in Modern Oncology. | Halabi S et al. | β | 2019 | β |
| Differential impact of classical and non-canonical NF-ΞΊB pathway-related gene expression on the survival of breast cancer patients. | Espinoza-SΓ‘nchez NA et al. | β | 2019 | β |
| Do cancer stem cells exist? A pilot study combining a systematic review with the hierarchy-of-hypotheses approach. | Bartram I et al. | β | 2019 | β |
| Dynamic Emergence of Observed and Hidden Intra-tumor Heterogeneity. | Raynaud F et al. | β | 2019 | β |
| EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells. | Rodriguez-Aznar E et al. | β | 2019 | β |
| Epigenetic heterogeneity in cancer. | Guo M et al. | β | 2019 | β |
| Estimating the predictability of cancer evolution. | Hosseini SR et al. | β | 2019 | β |
| Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential. | Singh B et al. | β | 2019 | β |
| Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer. | Masoodi T et al. | β | 2019 | β |
| Extensive subclonal mutational diversity in human colorectal cancer and its significance. | Loeb LA et al. | β | 2019 | β |
| Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas. | Yang C et al. | β | 2019 | β |
| Head and neck cancer management and cancer stem cells implication. | Elkashty OA et al. | β | 2019 | β |
| Hiding in Plain Sight: Epigenetic Plasticity in Drug-Induced Tumor Evolution. | Sharma A | β | 2019 | β |
| Histo-genomics: digital pathology at the forefront of precision medicine. | Barsoum I et al. | β | 2019 | β |
| Identity determination in diagnostic surgical pathology. | Pfeifer JD | β | 2019 | β |
| Implications of non-uniqueness in phylogenetic deconvolution of bulk DNA samples of tumors. | Qi Y et al. | β | 2019 | β |
| Integrating radiomics into clinical trial design. | Waninger JJ et al. | β | 2019 | β |
| Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data. | Malikic S et al. | β | 2019 | β |
| Intracellular pH dynamics and charge-changing somatic mutations in cancer. | White KA et al. | β | 2019 | β |
| Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells. | San-MillΓ‘n I et al. | β | 2019 | β |
| Levels Propagation Approach to Image Segmentation: Application to Breast MR Images. | Bouchebbah F et al. | β | 2019 | β |
| Mathematical modelling the pathway of genomic instability in lung cancer. | Li L et al. | β | 2019 | β |
| Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. | Rambow F et al. | β | 2019 | β |
| Metabolic Alterations in Pancreatic Cancer Progression. | Vernucci E et al. | β | 2019 | β |
| Model genotype-phenotype mappings and the algorithmic structure of evolution. | Nichol D et al. | β | 2019 | β |
| Modeling dynamics for oncogenesis encompassing mutations and genetic instability. | Fassoni AC et al. | β | 2019 | β |
| Modeling genetic heterogeneity of drug response and resistance in cancer. | Laajala TD et al. | β | 2019 | β |
| Modeling heterogeneous tumor growth dynamics and cell-cell interactions at single-cell and cell-population resolution. | Harris LA et al. | β | 2019 | β |
| Molecular Heterogeneity of Papillary Thyroid Cancer: Comparison of Primary Tumors and Synchronous Metastases in Regional Lymph Nodes by Mass Spectrometry Imaging. | Gawin M et al. | β | 2019 | β |
| Multi-stage models for the failure of complex systems, cascading disasters, and the onset of disease. | Webster AJ | β | 2019 | β |
| Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence. | Wu P et al. | β | 2019 | β |
| Nano-GLADIATOR: real-time detection of copy number alterations from nanopore sequencing data. | Magi A et al. | β | 2019 | β |
| New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation. | Aghajani M et al. | β | 2019 | β |
| Noncoding RNAs and Liquid Biopsy in Lung Cancer: A Literature Review. | HaranguΘ A et al. | β | 2019 | β |
| NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods. | Roddy AC et al. | β | 2019 | β |
| Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma. | Wu Q et al. | β | 2019 | β |
| Parameter, noise, and tree topology effects in tumor phylogeny inference. | Tomlinson K et al. | β | 2019 | β |
| PRISM: methylation pattern-based, reference-free inference of subclonal makeup. | Lee D et al. | β | 2019 | β |
| Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues. | Persi E et al. | β | 2019 | β |
| Rapid evolution and biogeographic spread in a colorectal cancer. | Alves JM et al. | β | 2019 | β |
| Replication stress triggers microsatellite destabilization and hypermutation leading to clonal expansion in vitro. | Matsuno Y et al. | β | 2019 | β |
| Revealing tumor heterogeneity of breast cancer by utilizing the linkage between somatic and germline mutations. | Zou M et al. | β | 2019 | β |
| Separating the Local and Malignant Dimensions of Cancer Adaptation. | Roche B et al. | β | 2019 | β |
| SiCloneFit: Bayesian inference of population structure, genotype, and phylogeny of tumor clones from single-cell genome sequencing data. | Zafar H et al. | β | 2019 | β |
| Significant random signatures reveals new biomarker for breast cancer. | Saberi Ansar E et al. | β | 2019 | β |
| Somatic evolution and global expansion of an ancient transmissible cancer lineage. | Baez-Ortega A et al. | β | 2019 | β |
| SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq. | Kim M et al. | β | 2019 | β |
| Stochastic modeling of phenotypic switching and chemoresistance in cancer cell populations. | Kumar N et al. | β | 2019 | β |
| Summarizing the solution space in tumor phylogeny inference by multiple consensus trees. | Aguse N et al. | β | 2019 | β |
| Targeting cancer stem cells in squamous cell carcinoma. | Chen D et al. | β | 2019 | β |
| The concept of leukaemic stem cells in acute myeloid leukaemia 25Β years on: hitting a moving target. | Hokland P et al. | β | 2019 | β |
| The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind? | Loponte S et al. | β | 2019 | β |
| The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology. | Natali F et al. | β | 2019 | β |
| The Order of Cancer: A Theory of Malignant Progression by Inverse Morphogenesis. | HΓΆckel M et al. | β | 2019 | β |
| The Role Of Circulating Tumor DNA In Therapeutic Resistance. | Xu C et al. | β | 2019 | β |
| The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis. | Roberts CM et al. | β | 2019 | β |
| Tumor diversity and the trade-off between universal cancer tasks. | Hausser J et al. | β | 2019 | β |
| Tumor heterogeneity: does it matter? | Turnquist C et al. | β | 2019 | β |
| Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing. | Chen A et al. | β | 2019 | β |
| Tumorigenesis as the Paradigm of Quasi-neutral Molecular Evolution. | Chen B et al. | β | 2019 | β |
| Warburg and Krebs and related effects in cancer. | Unterlass JE et al. | β | 2019 | β |
| What Can Chemical Carcinogenesis Shed Light on the LNT Hypothesis in Radiation Carcinogenesis? | Trosko JE | β | 2019 | β |